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With prolonged lives thanks to antiretroviral therapy, parents living with HIV 
(PLH) face challenges regarding telling their HIV-positive status to children (i.e., 
parental HIV disclosure). With aims to assist PLH in making a well-planned and 
developmentally appropriate HIV disclosure to their uninfected children, a theory-driven 
intervention was conducted among 791 PLH with children aged between 6-15 years in 
Guangxi, China.   
Guided by the stage model of the Health Action Process Approach (HAPA), three 
critical disclosure stages were defined: 1) the pre-intention stage, in which people have 
not yet decided to disclose; 2) the intention stage, in which people have decided to 
disclose but have not yet started action; 3) the action stage, in which individuals make 
actual disclosure event. Accordingly, people at the three stages were defined as pre-
intenders, intenders, and actors.  
Using secondary data from the baseline (W1) and the first two follow-ups (W2 at 
6-month and W3 at 12-month) data, this dissertation evaluated the intervention effect on 
parental HIV disclosure stages and examined the roles disclosure-related psychosocial 
factors play in the process. Three major research questions were addressed: 1) is there 
any intervention effect on HIV disclosure stage transition between W2 and W3? 2) is 
there any intervention effect on disclosure-related psychosocial factors from W1 to W2 
and from W2 to W3? 3) do disclosure-related psychosocial factors at W2 yield stage-




To address the first question, a multigroup first-order manifest Markov Chain 
method was conducted to assess intervention effect on disclosure stage transitions 
between W2 and W3. Among pre-intenders at the first follow-up, those in the 
intervention group were more likely to progress to the action stage rather than being static 
(OR = 3.43, 95% CI 1.17, 10.01). However, no statistically significant intervention effect 
was detected in promoting progression from pre-intention to intention (OR = 1.02, 95% 
CI 0.47, 2.20). Among intenders at the first follow-up, no statistically significant 
intervention effect was detected in preventing backward transition to pre-intention (OR = 
0.71, 95% CI 0.35, 1.43) or promoting forward transition to action (OR = 2.01, 95% CI 
0.84, 4.79).  
To address the rest two questions, a proportional latent change score (LCS) 
method was used to assess intervention effect on disclosure-related psychosocial factors 
including knowledge, outcome expectancy (perceived costs and rewards), self-efficacy, 
and planning. Predictive effects of these psychosocial factors on disclosure stage 
transitions were examined by treating these factors as covariate in the Markov chain. At 
the first follow-up, statistically significant intervention effect was detected for disclosure 
knowledge, action self-efficacy, and action planning but not for disclosure outcome 
expectancy. Stage-specific predictive effects of action self-efficacy and action planning 
on HIV disclosure stage transitions were detected.   
Findings from the dissertation have significant implications for future studies. 
First, the 3-stage HAPA model can be applied to the evaluation of HIV disclosure 
interventions. Second, the identification of stage-specific psychosocial predictors of stage 
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1.1 HIV EPIDEMIC 
1.1.1 Global HIV epidemic  
According to the Joint United Nations Programme on HIV and AIDS (UNAIDS), 
by the end of 2018, there were 37.9 million people living with HIV (PLHIV) worldwide 
(Joint United Nations Programme on HIV/AIDS, 2019). Among 36.2 million adults (aged 
between 15 and 49 years old) living with HIV, 18.8 million (52%) were women. Data 
from the World Health Organization (WHO) showed that the prevalence of HIV among 
adults aged between 15 and 49 years old was 0.8% worldwide, which ranged between 
0.1% (in Eastern Mediterranean and Western Pacific) and 3.9 (in Africa) (World Health 
Organization, 2019).  
In 2014, UNAIDS launched its ambitious 90-90-90 target for 2020. Simply, 90% 
of PLH would know their HIV status, 90% of people diagnosed with HIV infection 
would receive treatment, and 90% of PLH on treatment would reach viral suppression. 
Based on the 2019 UNAIDS data, by the end of 2018, 79% of PLH have known their 
HIV status, 78% of PLH who know their status have received treatment, and 86% of PLH 
on treatment have reached viral suppression (Joint United Nations Programme on 
HIV/AIDS, 2019). Six countries (Botswana, Cambodia, Denmark, Eswatini, Namibia and 




(Australia, France, Germany, Iceland, Ireland, Rwanda, Spain, Thailand, and United 
Kingdom) have reached the threshold of 73% regarding viral load suppression among all 
PLH yet gaps were identified particularly in the first two targets. Key populations, 
including men who have sex with men, people who inject drugs, sex workers, and 
transgender people, together with their sexual partners, accounted for 54% of new HIV 
infections worldwide. AIDS-related mortality has declined by 33% since 2010. 
Tuberculosis (TB) remains the leading cause of AIDS-related deaths. Data on 
government spending for HIV between 2016 and 2018 showed that among 70 low- and 
middle-income countries, 45 reported an increase in spending since 2010. An increase of 
more than 50% were reported by 36 countries.  
1.1.2 HIV epidemic in China 
As reported on the 5th National Conference on HIV/AIDS in China, there were 
820,756 reported people living with HIV (PLHIV) in China by the end of June 2018, 
among which 80.4% were receiving ART (China Center for Disease Control and 
Prevention, 2018). The 2019 UNAIDS data showed that in China, 83% of PLH who 
know their status have received the treatment, and 94% have suppressed viral loads (Joint 
United Nations Programme on HIV/AIDS, 2019). Although a low prevalence rate of 
0.037% was found for the overall population, high prevalence was detected in some areas 
(Yunnan, Sichuan, Guangxi) and among certain groups. The percentage of sexually 
transmitted cases among the newly diagnosed ones had increased from 33.1% in 2006 to 
92.2% in 2014, with heterosexual transmission increasing from 30.6% to 66.4% and 
becoming the dominant route of infection (National Health and Family Planning 




CDC, among newly diagnosed HIV cases in 2017, 69.6% were contracted via 
heterosexual sex, 25.5% were MSM, and 3.2% were drug injections (China Center for 
Disease Control and Prevention, 2018). China increased government spending on HIV 
from about US$ 400 million in 2010 to more than US$ 1 billion in 2018 (Joint United 
Nations Programme on HIV/AIDS, 2019). Based on the 2018 Global AIDS Monitoring 
Country Progress Report, from 2008 to 2017, the number of HIV testing medical and 
health facilities increased from 7,642 to 30,435 (Joint United Nations Programme on 
HIV/AIDS, 2018b).  
1.2 DEFINITION OF HIV DISCLOSURE 
As early as 1999, the WHO described HIV as “a process to inform others about 
one’s HIV positive status by the person himself or by a third party with or without 
consent” (World Health Organization, 1999). In the 2011 review of facilitating HIV 
disclosure across diverse settings, Obermeyer argued that “rather than being a one-time 
event, disclosure is often a gradual process of disclosing to an increasing number of 
others in one's networks over time” (Obermeyer, Baijal, & Pegurri, 2011). This definition 
has been used in the evaluation of partner HIV disclosure interventions. For example, 
partner disclosure rate was calculated by the proportion of partners to whom participants 
had disclosed among partners they had in the past 6 months (Conserve, Groves, & 
Maman, 2015).   
Regarding a specific disclosure target, in 2004, the World Health Organization 
(WHO) published a review paper on HIV disclosure (World Health Organization, 2004). 
The paper argues that disclosure should be conceptualized as a process rather than a one-




composed of decision-making, action, and post-disclosure adaptation. Such 
conceptualization has been incorporated in the Disclosure Process Model (DPM) which 
describes “how people make decisions to disclose and how people are affected by their 
disclosure decisions” (Chaudoir & Fisher, 2010).  
Specifically, existing literature has proposed and investigated the decision-making 
process of disclosure. For example, a 6-step process was developed by Kimberly 
(Kimberly, Serovich, & Greene, 1995). The first step is adjustment to the diagnosis. 
Appropriate adjustment to the diagnosis can help individuals develop personal acceptance. 
The second step is the assessment of personal disclosure skills. Individuals need to 
evaluate whether they have adequate level of skills necessary for disclosure. The third 
step is the assessment of the potential disclosure recipient. Individuals may go through 
members in their social network and choose an individual as the disclosure recipient. The 
fourth step is the assessment of the circumstances for disclosure. Some circumstances 
may not be appropriate for disclosure to certain individuals. The fifth step is the 
anticipation of recipients’ potential reactions. The final step is the identification of 
disclosure motivation.  
1.3 OUTCOMES OF HIV DISCLOSURE 
According to the DPM, disclosure can affect both individual, dyadic, and social 
contextual outcomes (Chaudoir & Fisher, 2010). Individual outcomes include 
psychological, behavioral, and physical well-being, dyadic outcomes include liking, 
intimacy, and trust, social contextual outcomes include cultural stigma and norms for 
disclosure. For the person who discloses, HIV disclosure was associated with initiation of 




well as higher levels of social support and closer relationships with the disclosure 
recipient (Bulali, Kibusi, & Mpondo, 2018; Dessie et al., 2019; Hodgson et al., 2014; 
Mayfield Arnold, Rice, Flannery, & Rotheram-Borus, 2008; Stutterheim et al., 2011; 
Weiss, 2004). Specifically, for partner disclosure, awareness of partner’s HIV status 
allows the disclosure recipient to get HIV testing and negotiate safer-sex practices, which 
is critical for the risk reduction of HIV transmission (Conserve et al., 2015). However, 
HIV disclosure may not always be associated with positive outcomes. HIV disclosure can 
lead to HIV-related stigma, blame, abandonment, physical and emotional abuse, worse 
partner relationship, and loss of social support (Chaudoir, Fisher, & Simoni, 2011; Hawk, 
2007; Mayfield Arnold et al., 2008; Stutterheim et al., 2011; Weiss, 2004).  
1.4 PSYCHOSOCIAL FACTORS INFLUENCING DISCLOSURE DECISION-MAKING  
Several key psychosocial factors have been identified to influence the decision-
making of disclosure. According to the consequence theory of HIV disclosure, people 
assess the rewards and costs for disclosure and a decision to disclosure is made once the 
rewards outweigh the costs (Serovich, 2001). Based on the Disclosure Decision-Making 
Model (DDMM), besides assessment of the costs and rewards for HIV disclosure, 
patients also evaluate their ability to disclosure (i.e., disclosure self-efficacy) (Greene et 
al., 2012). The individual’s likelihood to disclosure increases as disclosure self-efficacy 
increases.  
Moreover, different effects have been found regarding how these factors influence 
HIV disclosure behavior. For example, one study conducted among HIV positive MSM 
found that disclosure costs and self-efficacy predict HIV disclosure, while disclosure 




study conducted among HIV positive women found disclosure rewards to be a predictor 
for HIV disclosure, while disclosure costs were not (Serovich, Lim, & Mason, 2008).  
1.5 CHILDREN IN TERMS OF HIV DISCLOSURE 
Regarding children in HIV disclosure, most studies have focused on disclosure of 
a child’s HIV status (i.e., pediatric HIV disclosure). A systematic review on pediatric 
HIV disclosure differentiated disclosure as full disclosure, partial disclosure, no 
disclosure, and deflected disclosure (Britto, Mehta, Thomas, & Shet, 2016). Full 
disclosure involves the mentioning of HIV specifically. Partial disclosure involves 
mentioning the illness in a way that was consistent with HIV but without the term “HIV”. 
No disclosure means telling nothing about the illness. Deflected disclosure involves 
deceptive description of the illness by telling the children about less-stigmatized 
conditions (e.g., asthma, cancer) unrelated to HIV.  
In Tasker’s book, How Can I tell you, a four-phase disclosure model was 
described (Tasker, 1992). The first is the secrecy/privacy phase which occurs 
immediately after learning the child’s diagnosis. The second is the exploratory phase 
characterized by parents’ willingness to disclose to a close friend or family member. 
Meanwhile, the parent will often provide some information (not directly mentioning 
HIV) regarding the child’s illness and needs for medical visits. The third phase is the 
readiness phase characterized by parents’ willingness and planning of fully disclosing to 
the child. The fourth is the disclosure phase when parents fully disclosure to the child 






1.6 PARENTAL HIV DISCLOSURE 
1.6.1 Disclosure rate 
With prolonged lives thanks to ART, parents living with HIV (PLH) are more likely to 
raise their children to adolescence or even adulthood. Meanwhile, PLH face ongoing 
challenges regarding whether, when, and how to disclose their HIV-positive status to 
children (i.e., parental HIV disclosure). A systematic review found that parental HIV 
disclosure rate ranged from 20%-97% in high-income countries. Lower rates ranging 
from 11% to 44% were found in resource-constrained countries. According to the China 
Stigma Index Report, less than half of PLH reported that their children were aware of 
their HIV status (Institute of Social Development Research, 2009). An even lower rate of 
25% was found in the 2012 survey among 1254 PLH who had children between 5-16 
years old (Qiao et al., 2015).  
1.6.2 Disclosure outcomes 
Both positive and negative outcomes have been reported regarding parental HIV 
disclosure, both for the children, for the parent, and for the family(Conserve et al., 2015). 
For the children, although some studies reported short-term negative consequences on 
externalizing problems, internalizing behaviors, anxiety and depression, and school 
performance, others suggested that most children, particularly younger children, adjusted 
to parental HIV disclosure over time in terms of the aforementioned psychosocial 
functioning factors. For the parents, parental HIV disclosure was associated with better 
ART adherence and lower levels of depression and anxiety. Moreover, parents also 
reported higher levels of social support from the children, as well as a closer parent-child 




1.6.3 Barriers to parental HIV disclosure 
Relatively low disclosure rate can be caused by several barriers including 
concerns that children are too young to understand, poor parent-child relationship and 
family functioning, limited parent-child communication skills, and lack of accurate HIV 
knowledge (Clifford, Craig, McCourt, & Barrow, 2013).  
Regarding the concerns about children’s young age, studies on pediatric HIV 
disclosure argued that the disclosure should be conceptualized as a process “that 
considers the child’s social, emotional, and developmental level”(Cantrell, Patel, 
Mandrell, & Grissom, 2013). Based on Piaget’s cognitive development theory, three 
critical developmental stages are identified --- the preoperational stage, the concrete 
operational stage, and the formal operational stage. A structured sequence of HIV 
infection information was recommended for children at three different developmental 
stages with suggested ages being 6-7 years, 8-11 years, and 11-14 years, respectively.  
Regarding parent-child relation and family functioning, both quantitative and 
qualitative studies have found that poor parent-child relationship was a key barrier to 
parental HIV disclosure (Clifford et al., 2013; Kennedy et al., 2010; Osingada, Okuga, 
Nabirye, Sewankambo, & Nakanjako, 2017). Moreover, studies on parental HIV 
disclosure preparation activities have found that besides thinking about and making 
disclosure plans, PLH also tried to improve family relationships in order to better prepare 
their children for the upcoming disclosure (Gachanja, Burkholder, & Ferraro, 2014a).  
Regarding poor intergenerational communication skills, studies have suggested 
that intergenerational communication was the most modifiable causal pathway for 




focusing on the individual patient or considering the family only as a source of social 
support, family-based interventions emphasize the educational, relational, and personal 
needs of all family members (Fisher & Weihs, 2000).  
1.7 STAGE MODELS TO FILL THE INTENTION-BEHAVIOR GAP 
The relatively low parental HIV disclosure rate can also be due to the failure of 
translating disclosure intention to disclosure behavior (i.e., the intention-behavior gap). 
Studies examining HIV disclosure to partners showed significantly lower actual 
disclosure rates compared to intended disclosure rates in both developed and developing 
countries (Maman & Medley, 2007).  
To fill the intention-behavior gap, researchers argued that stage models of 
behavior change should be applied (Schwarzer, 2016; Velicer & Prochaska, 2008). 
Specifically, the stage models posit that people pass through an ordered set of 
qualitatively different stages to make behavior change (Weinstein, Rothman, & Sutton, 
1998). Based on the Transtheoretical Model (TTM), individuals move through five stages 
of change: 1) the pre-contemplation, in which people do not intend to take action within 
the next 6 months; 2) the contemplation, in which people intend to change within the next 
6 months; 3) the preparation, in which people intend to take action usually within the next 
month; 4) the action, in which people have made specific overt behavior change within 
the past six months; 5) the maintenance, in which people have made specific overt 
behavior change for more than 6 months.  
Although the TTM has been widely used in physical activity, smoking cessation, 
and substance use cessation interventions, it is not readily applicable for the HIV 




behavior or behavioral intention. Specifically, for the pre-action stages, differentiation 
between the preparation stage and the contemplation stage is based on whether there’s an 
intention to make immediate (i.e., within the next month) behavior change or not. It fails 
to capture the preparation and planning component which plays a key role in translating 
disclosure intention into actual behavior. For the post-action stages, differentiation based 
on the duration of a certain behavior fails to capture the feature of HIV disclosure action 
which may progress in terms of depth and width, but not duration.  
As argued in the HAPA (Schwarzer, 2016), the intention-behavior gap can be 
bridged by adopting the stage models where the role of action planning (i.e., making 
“When-Where-How” plans) is pinpointed. HAPA posits that engaging in behavior 
change starts with forming an intention, followed by a stage of planning, and ends in 
action. Briefly, there are three critical stages: 1) the pre-intention stage, in which people 
have not yet decided to act; 2) the intention stage, in which people have decided to act 
and started making plans but have not yet started action; 3) the action stage, in which 
individuals make actual behavior change.  
1.8 RESEARCH GAPS IN PROGRAM EVALUATION 
Although HIV disclosure has been depicted as a process with several key steps, 
such conceptualization has not been incorporated in the evaluation of parental HIV 
disclosure interventions. In a systematic review of existing parental HIV disclosure 
interventions, intervention effects have been evaluated focusing on the actual HIV 
disclosure action rather than the process (Conserve et al., 2017). Moreover, although 
HAPA has been applied to behavior change interventions on physical exercise, smoking 




in depicting HIV disclosure process. Therefore, the stage-specific predicting roles of key 
psychosocial factors such as outcome expectancy and self-efficacy have not been well 
studied in the context of HIV disclosure.  
1.9 AIMS OF THE DISSERTATION STUDY   
To address the research gaps in HIV disclosure intervention evaluation, this 
dissertation project aims to apply the HAPA model to the program evaluation of an 
existing parental HIV disclosure intervention. This dissertation project builds on the 
“Interactive Communication with Openness, Passion, and Empowerment” (ICOPE) 
intervention funded by an NIH R01 (Principal investigator: Dr. Xiaoming Li). Aimed at 
assisting PLH to make a well-planned and developmentally appropriate HIV disclosure to 
their uninfected children, a theory-driven intervention was conducted among 791 PLH 
with children aged between 6-15 years in Guangxi, China. Participants receive interactive 
training sessions focusing either on cognitive and behavioral skills regarding parental 
HIV disclosure (i.e., the intervention group) or on nutrition education (i.e., the control 
group). Participants completed the baseline survey before intervention and 6 waves of 
follow-ups were conducted every 6 months.  
This dissertation research project will contribute to the theoretical aspect of HIV 
disclosure research by 1) applying the HAPA to the operationalization of HIV disclosure 
stage; 2) evaluate the intervention effects of a theory-based parental HIV disclosure 
intervention on HIV disclosure stage; 3) evaluate the intervention effects of a theory-
based parental HIV disclosure intervention on disclosure-related psychosocial factors; 4) 
assess the predictive effects of disclosure-related psychosocial factors on HIV disclosure 




1) is there any intervention effect on HIV disclosure stage transitions?  
2) is there any intervention effect on disclosure-related psychosocial factors?  
3) do disclosure-related psychosocial factors yield stage-specific predictive effects 







BACKGROUND AND SIGNIFICANCE 
2.1 PROBLEM STATEMENT 
According to the Joint United Nations Programme on HIV and AIDS (UNAIDS), 
by the end of 2018, there were 37.9 million people living with HIV (PLHIV) worldwide 
(Joint United Nations Progamme on HIV/AIDS, 2019). As reported on the 5th National 
Conference on HIV/AIDS in China, by the end of June 2018, there were 820,756 
reported PLHIV in China, among which 80.4% were receiving ART (China Center for 
Disease Control and Prevention, 2018). The 2019 UNAIDS data reported that 83% of 
PLH in China who know their status have received the treatment, and 94% have reached 
viral suppression(Joint United Nations Programme on HIV/AIDS, 2019).  
China national statistics showed that HIV infections were largely concentrated in 
the childbearing 20–29 and 30–39 age groups, which together account for 70.0% of all 
infections (Huang et al., 2015). A cross-sectional survey conducted in 2012 among 2987 
PLHIV in Guangxi, China showed that most (n=2458; 82.3%) participants had at least 
one child. With prolonged lives thanks to ART, parents living with HIV (PLH) are more 
likely to raise their children to adolescence or even adulthood. Over the course of their 




parental HIV disclosure). According to the China Stigma Index Report, less than half of 
PLH reported that their children were aware of their HIV status (Institute of Social
Development Research, 2009). Parental HIV disclosure is even more challenging when it 
comes to younger children. A disclosure rate of 25% was found in the 2012 survey 
among 1254 PLH who had children between 5-16 years old (Qiao et al., 2015).  
In 2011, the World Health Organization (WHO) published the Guideline on HIV 
Disclosure Counselling for Children Up to 12 Years of Age (World Health Organization, 
2011). Although the guideline has been focused on pediatric HIV disclosure (i.e., 
disclosing children’s HIV status), it also provided some recommendations that children of 
school age should be told of their parent’s HIV status. Specifically, considering the 
developmental stage of younger children, HIV disclosure should be conducted 
incrementally to accommodate their cognitive skills and emotional maturity. Till now, 
there’s no standardized guideline regarding parental HIV disclosure counseling services 
launched in China.  
2.2 THEORETICAL MODELS OF PARENTAL HIV DISCLOSURE INTERVENTIONS 
2.2.1 Social Cognitive Theory (SCT) 
Bandura (Bandura, 1994) posited the Social Cognitive Theory of HIV-related 
behaviors. The author highlighted that although knowledge of health risks and constituent 
skills are important preconditions for self-directed change, people need to be provided 
with the behavioral means, resources, and social supports for behavioral changes. The 
two central tenets of the theory are outcome expectancies and self-efficacy. In terms of 




outweigh the costs. In terms of self-efficacy, a person needs to believe that he or she can 
implement a certain behavior with acquired skills under counteracting circumstances.  
Specifically, for parental HIV disclosure, outcome expectancies can be either 
positive (i.e., the anticipation of social approval or recognition by the child) or negative 
(i.e., the anticipation of rejection from the child). Self-efficacy regarding parental HIV 
disclosure is defined as the perceived ability to conduct the disclosure event in a 
successful manner.  
2.2.2 The Disclosure Decision-Making Model (DDMM) 
Built on several theoretical perspectives including the social cognitive theory, 
Greene et al. (Greene et al., 2012) posited the Disclosure Decision-Making Model 
(DDMM) with an emphasis on key predictors of disclosure likelihood and disclosure 
depth. Separate models were developed for the likelihood of disclosure and for disclosure 
depth among people who have already disclosed. Briefly, the DDMM argues that people 
make disclosure decisions based on the evaluation of three major factors: the diagnosis 
(the information), the potential receiver of disclosure, and the disclosure self-efficacy. 
The five major components in the information are stigma, disease prognosis, disease 
symptoms, discloser’s preparation, and the relevance of the diagnosis to others. In terms 
of assessing the potential receiver, the discloser evaluates the relationship quality, the 
anticipated reaction (including both short-term reaction and long-term consequence), and 
the confidence in response (i.e., the certainty that the receiver will respond in the way that 






2.2.3 The Disclosure Process Model (DPM) 
With the two aforementioned models focusing on the decision-making process of 
disclosure, the Disclosure Process Model (DPM) posited by Chaudoir et al. (Chaudoir et 
al., 2011) incorporated disclosure outcomes as a key component of HIV disclosure. 
Similar to the DDMM, the decision-making of HIV disclosure depends on the antecedent 
goals, and the disclosure event is characterized by the depth, duration, and breadth of the 
disclosure. Moreover, the reaction of the confidant was added to comprehensively 
measure disclosure event. In terms of disclosure outcomes, both the individual-, dyadic- 
and social contextual- level factors were taken into consideration. One key feature of the 
DPM is the mediating process linking the disclosure event to disclosure outcomes. In 
addition, the DPM recognizes the reciprocity of disclosure by adding the feedback loop 
linking disclosure outcomes back to the decision-making process of future disclosure.  
2.3 PSYCHOSOCIAL FACTORS INFLUENCING HIV DISCLOSURE 
Several psychosocial factors have been identified to influence HIV disclosure in 
the three models mentioned above. The first is outcome expectancy. According to the 
consequence theory of HIV disclosure, people assess the rewards and costs for disclosure 
and a decision to disclosure is made once the rewards outweigh the costs (Serovich, 
2001). Defined as “anticipated reaction”, the DDMM further differentiated anticipated 
response (i.e., immediately after the disclosure) and anticipated outcome (i.e., the 
endpoint results of the disclosure). In DPM, outcome expectancy was defined as 
antecedent goals with the approach goals as pursing rewards and avoidance goals as 




The second factor is self-efficacy, which refers to patients’ confidence in their 
ability to disclosure (Greene et al., 2012). Aligning with Bandura’s argument that self-
efficacy should be measured for a specific task, the DDMM specified that disclosure self-
efficacy refers to sharing the diagnosis, not general communication. The individual’s 
likelihood of disclosure increases as disclosure self-efficacy increases. Moreover, for 
those who have disclosed, higher levels of disclosure self-efficacy relate to higher levels 
of disclosure depth.  
Besides outcome expectancy and self-efficacy, the DDMM identifies an 
additional construct called “confidence in response”. It refers to the discloser’s level of 
certainty regarding how the disclosure target would respond. Although not directly 
related to the likelihood of disclosure, confidence in response was hypothesized to 
influence the likelihood via disclosure self-efficacy. A similar construct “likelihood of the 
anticipated outcome” was posited in the HIV disclosure anxiety model (Evangeli & 
Wroe, 2017).  
2.4 PARENTAL HIV DISCLOSURE INTERVENTION PROGRAMS  
Considering the potential benefits of disclosing HIV status to children, several 
interventions have been conducted to assist PLH with parental HIV disclosure. This 
section will review the evaluation of previous parental HIV disclosure interventions.  
2.4.1 Interventions based on the Social Cognitive Theory (SCT) 
Rotheram-Borus et al. (Rotheram-Borus, Lee, Gwadz, & Draimin, 2001) 
implemented a randomized controlled trial among 307 PLH with adolescent children in 
the US. The intervention group received two modules with the first model involving 




covered topics on coping with HIV and disclosure decision-making. Topics in Module 2 
covered both parent topics (e.g., making custody plans, parent-child communication) and 
youth topics (e.g., coping with parent’s illness and resolving family conflicts). The 
control group received standard HIV care. Follow-ups were conducted every 3 months 
over 2 years. Disclosure outcome variable was whether the parent disclosed to his/her 
child or not. The results showed no statistically significant difference in disclosure 
between the intervention group and the control group.  
2.4.2 Interventions based on the Disclosure Decision Making Model (DDMM) 
The Amagugu intervention with a pre- and post- design was developed and pilot 
tested among 24 HIV-positive mothers with children aged 6-9 years in rural South Africa 
(Rochat, Mkwanazi, & Bland, 2013). The intervention was further scaled up to 281 HIV-
positive mothers with children aged 6-10 years in rural South Africa (Rochat, Arteche, 
Stein, Mkwanazi, & Bland, 2014). Six structured counseling sessions covering two 
intervention stages were delivered. The pre-disclosure stage involved preparing and 
training the mother to disclosure, and the post-disclosure stage involved counseling on 
health promotion and custody planning. Impact evaluation was conducted immediately 
after the 6- to 8-week intervention. Disclosure outcome variable was whether participants 
partially, fully, or not disclosed to their child. In the first study, 11/24 fully disclosed to 
their children and 13/24 partially disclosed. In the second study, 60% of participants fully 
disclosed and 40% partially disclosed.  
The “Teaching, Raising, And Communicating with Kids” (TRACK) program was 
developed by Murphy et al. (Murphy, Armistead, Marelich, Payne, & Herbeck, 2011) and 




The intervention targets familial communication and parenting skills in the context of 
parental HIV disclosure. In the intervention group, participants received 3 sessions with 
topics on children’s development, benefits and risks of parental HIV disclosure, and 
parent-child communication. Behavioral exercises for disclosure were also practiced. In 
the control group, participants received standard care. Follow-ups were conducted every 
3 months over the next 9 months. Disclosure outcomes included whether participants 
disclosed to their children or not and disclosure self-efficacy. The results showed that 
participants in the intervention group were 6 times more likely to disclose their HIV 
status to their children (OR = 6.33, 95% 1.64, 24.45). A statistically significant increase 
in disclosure self-efficacy was also found.   
2.4.3 Interventions based on the Decision Process Model (DPM) 
Simoni et al. (Simoni et al., 2015) implemented a randomized controlled trial built 
on the Chinese Parental HIV Disclosure Model (which was adapted from the DPM) 
among 20 PLH in China. The intervention group received three counseling sessions 
regarding disclosure decision-making, HIV disclosure event, and disclosure 
consequences. In session one, participants shared stories of their HIV diagnosis and their 
current disclosure status (to partners or family members) with the nurse interventionist. In 
session 2, the nurse provided psycho-education regarding what to be expected from their 
children during the disclosure process. In session 3, participants developed a plan for 
achieving a certain goal along the disclosure continuum. The control group received 
standard care. Follow-ups were conducted immediately after the 4-week intervention, and 
at 13 weeks. Disclosure continuum was measured with a 7-point scale ranging from no 




distress and self-efficacy were also measured. The results showed statistically significant 
decrease in disclosure distress (OR = 0.17, 95% CI 0.03, 0.91), increase in self-efficacy 
(OR = 9.00, 95% CI 2.06, 39.29), as well as shift towards the higher end of the disclosure 
continuum (β=1.40, 95% CI 0.31, 2.50).  
2.5 METHODOLOGICAL GAPS IN IMPACT EVALUATION OF PARENTAL HIV 
DISCLOSURE INTERVENTIONS  
2.5.1 HIV disclosure as a process 
HIV disclosure has been described as a process of decision-making to determine 
whether, when, and how to disclose (Omarzu, 2000). The first stage is about disclosure 
intention formation and the latter two stages are about preparation and planning for 
intention translation. The HIV/AIDS Resources & Community Health (ARCH) published 
an HIV Disclosure Guide (HIV/AIDS Resources & Comunity Health, 2016). HIV 
disclosure is depicted as a process starting from recovery from the diagnosis and self-
educating, moving into preparation and planning for disclosure, and finally translating 
into disclosure action. In the preparation and planning phases, patients create disclosure 
plans by setting disclosure goals, deciding where, when, and how to disclose, as well as 
seeking disclosure support.  
However, among most parental HIV disclosure interventions, intervention effects 
have been evaluated focusing on the actual HIV disclosure action rather than the process. 
Two studies measured HIV disclosure action as a binary yes-or-no measure, one 
measured disclosure as no disclosure, partial disclosure using the word virus, and full 
disclosure using the word HIV, and one measured disclosure as a 0-6 scale ranging in 




knowledge, no measure has been developed to measure HIV disclosure process starting 
from intention-formation and ending in disclosure action.  
2.5.2 Other HIV disclosure-related outcomes 
As suggested by Simoni et al. (2015), HIV disclosure interventions should “aim 
more to diminish distress than achieve a specific behavioral outcome” (Simoni et al., 
2015). Therefore, disclosure beliefs, HIV disclosure distress, and disclosure self-efficacy 
need to be considered in impact evaluations of HIV disclosure interventions (Simoni et 
al., 2015).  
Moreover, HIV disclosure is a process that takes time. A study among PLH in 
Kenya showed that the preparation for disclosure often took several years before the 
actual disclosure event (Gachanja et al., 2014a). In addition, the intention-behavior gap 
identified in multiple health behaviors also exists in terms of HIV disclosure. Studies 
examining HIV disclosure to partners showed significantly lower actual disclosure rates 
compared to intended disclosure rates in both developed and developing countries 
(Maman & Medley, 2007). Therefore, single long-term measures such as the HIV 
disclosure event may fail to capture the short- to medium-term efficacy of interventions 
in terms of changes in disclosure-related psychosocial factors.  
2.6 HEALTH ACTION PROCESS APPROACH  
The stage models of behavior change have been widely used to depict the process 
of making behavior change (Schwarzer, 2016; Velicer & Prochaska, 2008). Specifically, 
the stage models posit that people pass through an ordered set of qualitatively different 
stages to make behavior change (Weinstein et al., 1998). Among existing stage models, 




According to HAPA, engagement in behavior change starts with forming an intention, 
followed by a stage of planning, and ends in action. Briefly, there are three critical stages: 
1) the pre-intention stage, in which people have not yet decided to act; 2) the intention 
stage, in which people have decided to act and started making plans but have not yet 
started action; 3) the action stage, in which individuals make actual behavior change. 
However, to the best of our knowledge, the HAPA has never been applied in HIV 
disclosure research.  
The importance of psychosocial factors such as outcome expectancy and self-
efficacy is emphasized in HAPA. Outcome expectancy is defined as beliefs about the 
positive and negative outcomes of the anticipated behavior, and self-efficacy is defined as 
one’s confidence in being capable of performing the behavior (Schwarzer, 2016). 
Different stages are characterized by psychological similarities within stages and 
psychological differences between stages (Schüz, Sniehotta, Mallach, Wiedemann, & 
Schwarzer, 2008). Theoretically, pre-intenders will show lower perceived rewards and 
self-efficacy but higher perceived costs than intenders. Intenders will show lower self-
efficacy than actors, but no differences in perceived costs or rewards are expected. 
Therefore, for pre-intenders, higher levels of perceived rewards and self-efficacy, as well 
as lower levels of perceived costs, would promote stage progression. For intenders, 
higher levels of self-efficacy would promote stage progression, while lower levels of 
costs and higher levels of rewards would prevent stage regression.  
As emphasized by HAPA, as people pass different stages to make behavior 
change, self-efficacy should be differentiated by the stages of change (i.e., intention-




Action self-efficacy plays a key role in the early intention formation stage. People with 
high action self-efficacy tend to imagine potential outcomes of diverse strategies and are 
more likely to initiate a new behavior. People with low action self-efficacy are more 
likely to imagine failure and tend to procrastinate (Schwarzer, 2011).   
In addition, the HAPA posits that planning precedes the initiation of behavior 
change action. By planning, the intention is more likely to be translated into action. 
Further differentiation is made between action planning (i.e., when-where-how plans) and 
coping planning (i.e., anticipating barriers and developing corresponding self-regulatory 
strategies). Specifically, for HIV disclosure, patients create disclosure plans by setting 
disclosure goals, deciding where, when, and how to disclose, as well as seeking 
disclosure support (HIV/AIDS Resources & Comunity Health, 2016). 
Although psychosocial factors such as disclosure self-efficacy have been 
considered in program evaluation of previous parental HIV disclosure interventions, as 
HIV disclosure has not been operationalized as a 3-stage process, limited understanding 
has been developed regarding whether such psychosocial factors yield stage-specific 
roles on HIV disclosure stage transition as hypothesized in HAPA.  
2.7 CONCEPTUAL FRAMEWORK 
The proposed dissertation was guided by the conceptual framework diagrammed 
in Figure 2.1. There were two main studies in this dissertation. The first study 1) 
modelled the HIV disclosure stage (pre-intention, intention, and action) and the transition 
matrix based on the 3-stage HAPA, and 2) evaluated intervention effects on HIV 
disclosure stage transition. The second study evaluated 1) intervention effects on parental 










• Perceived costs 
• Perceived rewards 
• Action self-efficacy 
• Action planning 
 
Intervention 
HIV disclosure stage transition matrix 
expectancy including the perceived costs and rewards, disclosure action self-efficacy, and 
disclosure action planning), and 2) the stage-specific predictive effects of these factors on 
HIV disclosure stage transition.  
2.8 PURPOSE 
The HAPA has been widely used in behavior change interventions on smoking 
cessation, physical exercise, nutrition, and dental health. However, less is known about 
whether this model is applicable to HIV disclosure intervention. Given the lack of 
research applying the stage models to the operationalization of HIV disclosure process, 
one of the main purposes of the proposed study is to model HIV disclosure stages based 











Moreover, although several key psychosocial factors have been identified in 
leading HIV disclosure models, previous studies have focused on the linear relationship 
between psychosocial predictors and the likelihood of disclosure action. Little is known 
about whether such factors yield stage-specific predictive effects of HIV disclosure stage 
transitions. Therefore, the other purposes of this study are to evaluate intervention effects 
on the proposed psychosocial factors, as well as to examine how these factors influence 
HIV disclosure stage transitions.  
The proposed research will build on past research on HIV disclosure by 
conceptualizing and operationalizing it as a process. Instead of focusing on actual HIV 
disclosure behavior, such operationalization gives credits to participants who make 
progress in the early stages before HIV disclosure action is conducted. Moreover, it will 
expand the application of HAPA to the HIV disclosure field by adopting the 3-stage 
definition as well as examining the role action self-efficacy plays in disclosure stage 
transition. Lastly, by assessing the potential stage-specific predictive effects of 
psychosocial factors, this study will provide evidence for the development of future 
stage-specific psychosocial interventions tailored to participants at different disclosure 
stages.  
2.9 RESEARCH QUESTIONS 
Three major research questions were addressed in this study.  
I. Is there any intervention effect on HIV disclosure stage transitions?  




b. Does the intervention influence the overall pattern of HIV disclosure stage 
transition (i.e., backward transition or forward transition)? 
II. Is there any intervention effect on disclosure-related psychosocial factors? 
a. Does the intervention improve participants’ knowledge regarding parental HIV 
disclosure? 
b. Does the intervention improve participants’ perceived rewards regarding 
parental HIV disclosure? 
c. Does the intervention decrease participants’ perceived costs regarding parental 
HIV disclosure? 
d. Does the intervention improve participants’ perceived action self-efficacy 
regarding parental HIV disclosure? 
e. Does the intervention improve participants’ perceived action planning 
regarding parental HIV disclosure? 
III. Do disclosure-related psychosocial factors yield stage-specific predictive 
effects on disclosure stage transition?  
a. How does knowledge regarding parental HIV disclosure influence HIV 
disclosure stage transition? 
b. How does perceived rewards regarding parental HIV disclosure influence HIV 




c. How does perceived costs regarding parental HIV disclosure influence HIV 
disclosure stage transition? 
d. How does action self-efficacy regarding parental HIV disclosure influence HIV 
disclosure stage transition? 
e. How does action planning regarding parental HIV disclosure influence HIV 





CHAPTER 3                                                          
METHODOLOGY 
3.1 STUDY SETTING 
This intervention was conducted in Zhuang Autonomous Region of Guangxi (i.e., 
Guangxi). Guangxi is a province on China’s southwestern border with Vietnam, with a 
total of 14 cities and 75 rural counties. It is a mountainous province with a large 
population of minority ethnic groups. Guangxi was ranked third among all the provinces 
of China in terms of HIV prevalence in the general population (1.30 per 1000) (Zheng et 
al., 2018). By the end of 2016, more than 110,000 people in Guangxi were registered to 
be living with HIV, among which 63,000 received treatment. Moreover, Guangxi was 
ranked second in terms of late HIV diagnosis, with a percentage of 51% much higher 
than the national average of 35.5% (Jin, Xiong, Wang, & Mao, 2016). Regarding the 
route of transmission, Guangxi was ranked the highest for heterosexual transmission. 
Among all registered HIV cases in 2016, more than 92% reported that they were infected 
by heterosexual sexual transmission (Zheng et al., 2018).   
To select participating sites, all 14 cities and 75 rural counties in Guangxi were 
ranked in terms of number of reported HIV/AIDS cases. The top two cities (urban 
centers) and the top eight rural counties with the largest number of reported HIV/AIDS 
cases were selected to participate. Next, primary public HIV clinics in urban districts of 




40 clinics were randomly selected from those clinics with at least 200 HIV/AIDS cases. 
About 20 PLH were randomly selected from each of the 40 participating clinics 
 To minimize the confounding of contextual factors, stratified cluster 
randomization was used to assign each clinic into either the intervention or the control 
conditions. Briefly, all 40 clinics were first stratified into 10 strata (4 clinics/stratum) 
based on their similarities in the number of PLHIV served and geographic locations (rural 
vs. urban). Within each stratum, two clinics were randomly assigned to the intervention 
group and the other two were assigned to the control group.  
3.2 STUDY SAMPLE 
Patients who have not disclosed their HIV infection to their seronegative children 
aged between 6 to 15 years of age were recruited from 40 participating clinics. Inclusion 
criteria were: at least 18 years of age; a confirmed diagnosis of HIV or AIDS; living with 
at least one child 6 to 15 years of age; having not disclosed their HIV status to their 
children; willing to consent one child to participate in the study. Exclusion criteria were: 
linguistic, mental or physical inability to respond to assessment questions or to participate 
in intervention; currently incarcerated or institutionalized for drug use or commercial sex; 
plan to permanently relocate outside of the province within a year. 
Medical staff or case managers at HIV clinics referred potential participants to 
local team members who visited each clinic twice a week during the recruitment period. 
If both father and mother in a family were eligible, the mother or the healthier parent was 
invited to participate. The project protocol was approved by the Institutional Review 
Boards (IRB) at Guangxi CDC in China and Wayne State University in the United States. 




3.3 INTERVENTION DELIVERY 
In each clinic, two nurses or other paraprofessionals were trained and certified to 
deliver the parent sessions (with separate training for intervention and control 
facilitators). The two trained facilitators delivered the materials through discussions, role-
play, exercise, and/or games (for group sessions). The five two-hour parent intervention 
and control sessions were delivered one session per week for five weeks in the clinics 
where the parents are recruited.  
3.4 DATA COLLECTION 
Interviewers administered the baseline and all six-month follow-up surveys to the 
parents in a private room (e.g., doctor’s office) at district/township clinics where these 
parents were recruited. The interviewer read each question in the questionnaire, and the 
participant gave an oral response to the interviewer. Clarifications were provided by the 
interviewers as needed. 
3.5 INTERVENTION CONTENTS 
3.5.1 Intervention group 
The parent curriculum consisted of five 2-hour interactive training sessions with 
three specific components: child development, illness communication, and coping. The 
first component focused on understanding the stages of childhood cognitive development 
in the context of parental illness (Session #1 “Child’s readiness for disclosure”). The 
second component focused on improving the parents’ cognitive and behavioral skills 
related to parental HIV disclosure (Session #2 “Benefits and risks of disclosure”, Session 




The third component focused on improving parental psychosocial well-being in adapting 
to living with HIV/AIDS (Session #5 “Cope with my infection/illness”).  
3.5.2 Control group 
The attention control condition for parents was five 2-hour sessions of nutrition 
education curriculum. The nutrition curriculum was modeled after the “Simply Good 
Eating” curriculum (Sherman et al., 2012) and modified in accordance with current 
“Dietary Guidelines for Chinese Residents” (Ge, Yang, & Chen, 2008). The modified 
curriculum consisted of five 2-hour interactive training sessions with aims to increase 
parents’ knowledge of nutrition (Session #1: Food variety; Session #2: Food for growing 
child), healthy diets and cooking practice (Session 3:  Fat, salt and sugar; Session 4:  
Fruits, vegetables and minerals), and food safety (Session #5 “Food safety”).  
3.6 KEY MEASURES 
3.6.1 Disclosure-related outcomes 
Primary outcome: HIV disclosure stage 
One question was asked at both follow-ups to capture individual’s level of HIV 
disclosure: 1 = “having not started disclosure in the past 6 months and no intention to 
start”, 2 = “having not started disclosure in the past 6 months but is intending to start”, 3 
= “having not started disclosure in the past 6 months but already made a plan”, 4 =  
“started disclosing but not mentioning HIV”, 5 = “started disclosing with the word HIV”, 
and 6 = “started disclosing with the word HIV and how I got infected”. This question was 






Secondary outcome: HIV disclosure-related psychosocial factors 
Participants were asked about their perceptions regarding the costs and rewards of 
parental HIV disclosure. Disclosure costs were measured with 4 questions (e.g., “do you 
agree that disclosing to children will impact their academic performance?”), and 
disclosure rewards were measured with 5 questions (e.g. “do you agree that children will 
provide more support after knowing your status?”). Responses ranged from 1 = 
“completely disagree” to 4 = “completely agree”.  
Considering the perceived costs and rewards depends on patients’ understanding 
of parental HIV disclosure, participants were also assessed on their knowledge regarding 
parental HIV disclosure using an author derived scale with 5 questions (e.g. “do you 
agree that parental HIV disclosure should take children’s developmental stage into 
consideration”). Responses ranged from 1 = “completely disagree” to 4 = “completely 
agree”.  
Participants’ action self-efficacy regarding parental HIV disclosure was measured 
with an author derived scale with 9 questions. Sample questions are “how confident are 
you that you can make a parental HIV disclosure plan?” and “how confident are you that 
you can talk with children about basic HIV/AIDS knowledge?”. Responses ranged from 
1 = “completely unconfident” to 5 = “completely confident”.  
Participants’ action planning regarding parental HIV disclosure was measured 
with an author derived scale with 9 questions. Three general questions regarding when, 
who, and how to disclose and 6 specific questions (e.g., “how to explain what HIV is”, 
“how to deal with children’s reaction”) were asked. Responses were 1 = “will never 




3.6.2 Baseline characteristics  
Parent-level variables include parents’ demographics (age, gender, marital status, 
level of education) and HIV-related variables (route of infection, and time since 
diagnosis, antiretroviral therapy uptake, CD4 count, viral load). Child-level variables 
include gender and age group (6-9 years, 10-12 years, and 13-16 years).  
3.7 ANALYSIS PLAN 
For the dissertation study, data from the baseline (W1) and the first two follow-
ups (W2 at 6 months and W3 at 12 months) were used. All analysis was conducted in 
Stata 13.0 (College Station, TX) and Mplus 7.4 (Muthén & Muthén).   
3.7.1 Randomization check 
Chi-square tests and multivariate analysis of variance (MANOVA) were used to 
investigate potential differences in baseline demographics and HIV-related variables. In 
case there were differences between groups, the respective variable(s) were used as 
covariates in the analysis of main outcome variables.   
3.7.2 Attrition analysis 
A CONSORT flowchart was provided (Figure 3.1). The rate of attrition and 
whether it varies between intervention assignment were examined using chi-square tests. 
MANOVA was conducted to test whether participants who completed the study differ in 
any baseline variables compared to those who dropped out. In case there were 
differences, the respective variable(s) were used as covariates in the analysis of the main 
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3.7.3 Main analysis 
Intervention effects on HIV disclosure stage transition from W2 to W3 
Methodologically, the central outcomes in stage theories such as HAPA are stage 
transitions, which can be modeled using Markov chain approaches. A simple illustration 
of the Markov chain is shown in Figure 3.2. C1 and C2 represent the latent stages at t and 
t+1, u1 and u2 represent the observed variables at t and t+1. Three sets of parameters are 
estimated: 1) latent status (i.e. stage) prevalence, which represents the prevalence of 



















given response to observed variable j, conditional on membership in a latent status s at 
time t; and 3) transition probabilities which represent the conditional probability of a 









A multigroup Markov model estimating group-specific transition matrix was 
conducted. In this way, the intervention arm was treated as a grouping variable, that is, 























Figure 3.2 Simple illustration of the Markov chain model 
Figure 3.3 Multigroup Markov model testing the moderating effect of the intervention on 









To yield statistical estimates of the intervention effects on the transition matrix, a 
different parameterization equivalent to the previous model was displayed in Figure 3.4. 
Intervention effects can be modelled using a conditional multinomial logistic regression 











Table 3.1 Illustration of the effect size of intervention on transitions 
 
 U2 
 1 2 3 
U1 1 b11+g11*Intervention b21+g21* Intervention 0 
2 b12+g12*Intervention b22+g22* Intervention 0 
3 0 0 0 
Note: The b parameters are slopes for the multinomial regression of U2 on U1. The g 
parameters are slopes for the intervention, varying over the U1 and U2 classes.  
 
Intervention effects on disclosure-related psychosocial factors 
A latent change score (LCS) method was used to evaluate the intervention effect 
on psychosocial factors. Both a structural model and a measurement model was included. 
Based on the classical test theory, an observed score Y[t]n can be decomposed into a true 
score y[t]n and a unique score u[t]n. This can be written as  




Y[t]n = y[t]n + u[t]n 
For the difference between two time points, the true score at time t (y[t]n) is a 
function of the true score at time t-1 (y[t−1]n) plus the change in the true score from time 
t-1 to t (Δy[t]n). This can be written as 
y[t]n = y[t-1]n + Δy[t]n 
Therefore, the latent different score can be written as  
Δy[t]n = y[t]n − y[t−1]n 
To model the latent different scores, the proportional change model was used. The 
predicted changes Δy[t]n are proportional to the state (or status) of the prior true score 
y[t−1]n. Simply, it can be written as  
Δy[t]n=β·y[t−1]n 
where β is an estimated parameter that does not vary over time. The model was 








Variance of y[t]n is decomposed into three parts: variance associated with one’s 
true score at t-1 (y[t−1]n), variance associated with the true change (Δy[t]n) from t-1 to t, 














In the structural model, the mean and variance of the first latent true score (M
1
) 









) were set to 
have a mean and a variance of 0. The autoregressive coefficients were set to 1. 
Intervention assignment was treated as a predictor of latent change scores. In the 
measurement model, the latent construct of interest was measured using several 
indicators (e.g., items 1-3). We assumed measurement invariance and correlated residual 
errors over time. The overall model was depicted in Figure 3.6.  
3.7.4 Missing data  
Cases with missing data on outcome variables at any follow-up wave were 
retained through the use of the full information maximum likelihood (FIML) estimator 
which gives valid estimates when missing data are MCAR or missing at random (MAR) 
(17). Complete-case analysis was conducted when data were missing on covariates. 
3.7.5 Clustering 
In the main analysis, a sandwich estimator of standard errors was used to account 
for the clustered nature of data (patients were nested within clinics). In addition, 
sensitivity analysis was conducted by applying the multi-level method (details in 
Appendix A). Simply, the mean and the variance were decomposed into the within-clinic 
level and the between-clinic level. The intervention was treated as a clinic-level covariate 
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 Figure 3.6 Structural modeling for the proportional latent change score (LCS) model 
 






4.1 INTERVENTION EFFECTS OF A THEORY-BASED PARENTAL HIV 
DISCLOSURE INTERVENTION AMONG PARENTS LIVING WITH HIV (PLH) IN 



















With prolonged lives thanks to antiretroviral therapy, ongoing challenges are 
faced by parents living with HIV (PLH) regarding telling their HIV-positive status to 
children (i.e., parental HIV disclosure). To assist PLH in making a well-planned and 
developmentally appropriate HIV disclosure to their uninfected children, a theory-driven 
intervention was conducted among 791 PLH with children aged between 6-15 years in 
Guangxi, China.   
Using secondary data from the baseline (W1) and the first two follow-ups (W2 at 
6-month and W3 at 12-month) data, intervention effect on HIV disclosure process was 
evaluated. Three critical disclosure stages were defined based on the stage model of the 
Health Action Process Approach (HAPA): 1) the pre-intention stage, in which people 
have not yet decided to disclose; 2) the intention stage, in which people have decided to 
disclose but have not yet started action; 3) the action stage, in which individuals make 
actual disclosure event. Accordingly, people at the three stages were defined as pre-
intenders, intenders, and actors.  
A multigroup first-order manifest Markov Chain method was conducted to assess 
the intervention effect on disclosure stage transitions between W2 and W3. Among pre-
intenders at the first follow-up, those in the intervention group were more likely to 
progress to the action stage rather than being static (OR = 3.43, 95% CI 1.17, 10.01). 
However, no statistically significant intervention effect was detected in promoting 
progression from pre-intention to intention (OR = 1.02, 95% CI 0.47, 2.20). Among 





in preventing backward transition to pre-intention (OR = 0.71, 95% CI 0.35, 1.43) or 
promoting forward transition to action (OR = 2.01, 95% CI 0.84, 4.79).  
Study findings suggest HIV disclosure can be modeled as a process with 3 stages 
guided by HAPA. Also, the stage-specific intervention effects suggest PLH at different 
stages may respond differently to the intervention. In order to develop stage-specific 
interventions tailored to parents’ needs, better understanding in terms of key psychosocial 
factors predicting HIV disclosure stage transitions is needed.  
Introduction 
By the end of 2017, there were 36.9 million people living with HIV (PLHIV) 
worldwide, among which 21.7 million were receiving antiretroviral therapy (ART) (Joint 
United Nations Programme on HIV/AIDS, 2018a). As reported on the 5th National 
Conference on HIV/AIDS in China, there were 820,756 reported PLHIV in China by the 
end of June 2018, among which 80.4% were receiving ART (China Center for Disease 
Control and Prevention, 2018). With prolonged lives thanks to ART, parents living with 
HIV (PLH) are more likely to raise their children to adolescence or even adulthood. The 
2012 survey showed that among 2458 PLH, 1043 (42.1%) had more than one adult 
children, and 1254 (50.6%) had at least one child between 5-16 years old.  
For PLH, telling their HIV-positive status to children (i.e., parental HIV 
disclosure) is challenging especially when it comes to younger children. According to the 
China Stigma Index Report, less than half of PLH reported that their children were aware 
of their HIV status (Institute of Social Development Research, 2009). An even lower rate 
of 25% was found in the 2012 survey among 1254 PLH who had children between 5-16 





In 2011, the World Health Organization (WHO) published the Guideline on HIV 
Disclosure Counselling for Children Up to 12 Years of Age (World Health Organization, 
2011). As there is evidence of mutual health benefits for both children and caregivers, 
parental HIV disclosure is recommended to school-aged children. Noticeably, a 2013 
systematic review of global literature on parental HIV disclosure reported mixed findings 
regarding the impacts of disclosure on children (Qiao, Li, & Stanton, 2013). As argued by 
the authors, a large number of parental disclosures were unintentional, poor-prepared, or 
even forced. This suggests the desired benefits of parental HIV disclosure may only be 
generated when it is culturally and developmentally appropriate and well-planned. 
According to Omarzu et al., HIV disclosure is a cognitive process to determine 
whether, when, and how to disclose (Omarzu, 2000). The first stage is about disclosure 
intention formation and the next two stages are about preparation and planning for the 
intention-to-action translation. In the HIV Disclosure Guide published by the HIV/AIDS 
Resources & Community Health (ARCH)  (HIV/AIDS Resources & Comunity Health, 
2016), HIV disclosure is depicted as a process starting from diagnosis adjustment and 
self-educating, moving into preparation and planning for disclosure, and finally 
translating into disclosure action. Great emphasis was put on the preparation and 
planning phases where patients create disclosure plans by setting disclosure goals, 
deciding where, when, and how to disclose, as well as seeking disclosure support.  
However, a dearth of interventions with aims to assist PLH with parental HIV 
disclosure have focused on the stage of disclosure process in the impact evaluation 
(Conserve et al., 2017). In the recent systematic review on parental HIV disclosure 





the primary outcome in the evaluation. Of these four intervention studies, two studies 
assessed intervention effect on HIV disclosure action as a binary yes-or-no measure, one 
study assessed intervention effect on disclosure as no disclosure, partial disclosure using 
the word virus, and full disclosure using the word HIV, and one study assessed 
intervention effect on disclosure as a 0-6 scale ranging in disclosure breadth (i.e., the 
topics covered in the communication).  
Considering the lack of studies viewing HIV disclosure decision-making as a 
process, we borrowed the conceptualization posited by the Health Action Process 
Approach (HAPA) stating that people pass through an ordered set of qualitatively 
different stages to make behavior change (Weinstein et al., 1998). According to HAPA, 
engagement in behavior change goes through the intention formation and the intention 
translation processes. Briefly, there are three critical stages: 1) the pre-intention stage, in 
which people have not yet decided to act; 2) the intention stage, in which people have 
decided to act but have not yet started action; 3) the action stage, in which individuals 
make actual behavior change (Schüz et al., 2008).  
Given that the central outcomes in stage theories such as HAPA are stage 
transitions, the current study focused on applying HAPA to evaluate intervention effects 
on HIV disclosure stage transitions. The primary research questions addressed were: (1) 
Does intervention condition affect specific stage transition probabilities; and (2) Does the 
intervention influence the overall pattern of HIV disclosure stage transition (i.e., 








a. Study setting 
This intervention was conducted in Guangxi, one of the regions with the highest 
prevalence of HIV in China. The HIV epidemic in Guangxi features a large number of 
newly reported HIV/AIDS cases, as well as multiple modes of HIV transmission (e.g., 
drug use, same-sex behavior, commercial sex behavior)(Zheng et al., 2018).  
The top two cities (urban centers) and the top eight rural counties with the largest 
number of reported HIV/AIDS cases were selected among all 14 cities and 75 rural 
counties to participate. Next, urban districts in the two cities and townships in the eight 
rural counties with at least 200 HIV/AIDS cases were identified, and a total of 40 clinics 
were randomly selected. To select participants, 20 PLH were randomly selected from 
each of the 40 participating clinics.  
 Stratified cluster randomization was used to assign each clinic into either the 
intervention or the control conditions. Briefly, all 40 clinics were first stratified into 10 
strata (4 clinics/stratum) based on their similarities in the number of PLHIV served and 
geographic locations (rural vs. urban). Within each stratum, two clinics were randomly 
assigned to the intervention group and the other two were assigned to the control group. 
Baseline survey and 6-waves of follow-ups (every 6 months) were conducted.  
b. Study sample 
Patients who have not disclosed their HIV infection to their seronegative children 
aged between 6 to 15 years of age were recruited from the participating primary public 
HIV clinics in the 40 districts/townships. Medical staff or case managers at HIV clinics 





week during the recruitment period. If both father and mother in a family were eligible, 
the mother or the healthier parent was invited to participate. The project protocol was 
approved by the Institutional Review Boards (IRB) at Guangxi CDC in China and Wayne 
State University in the United States. All participants provided written informed consent. 
c. Description of intervention 
1. Intervention contents  
Intervention group 
Three main components (child development, illness communication, and coping) 
were included for the intervention group. Child development focused on understanding 
the stages of childhood cognitive development in the context of parental illness and 
assessing the child’s readiness for disclosure. Illness communication focused on 
improving the parents’ cognitive (benefits and risks of disclosure, disclosure is an 
ongoing process) and behavioral skills (how to tell and what to tell) related to parental 
HIV disclosure. Coping focused on improving parental psychosocial well-being in 
adapting to living with HIV/AIDS.  
Control group 
The control group received nutrition education modeled after the “Simply Good 
Eating” curriculum (Sherman et al., 2012) and modified in accordance with current 
“Dietary Guidelines for Chinese Residents” (Ge et al., 2008). The modified curriculum 
aims to increase parents’ knowledge of nutrition, healthy diets and cooking practice, and 







2. Intervention delivery 
A two-hour session was delivered every week for five weeks in the clinics where 
the parents were recruited. At each clinic, two trained facilitators delivered the materials 
through discussions, role-play, exercise, and/or games.  
3. Data collection 
The baseline and a total of six-month follow-up surveys were administered to the 
parents in a private room (e.g., doctor’s office) at district/township hospitals where these 
parents were recruited. The interviewer read each question in the questionnaire, and the 
participant gave an oral response to each question. Clarifications were provided when 
needed. 
d. Measures 
1. HIV disclosure stage 
Participants’ HIV disclosure stage was measured using one question with 6 points: 
1 = “having not started disclosure in the past 6 months and no intention to start”, 2 = 
“having not started disclosure in the past 6 months but is intending to start”, 3 = “having 
not started disclosure in the past 6 months but already made a plan”, 4 =  “started 
disclosing but not mentioning HIV”, 5 = “started disclosing with the word HIV”, and 6 = 
“started disclosing with the word HIV and how I got infected”.   
The original 6 categories were collapsed into pre-intenders (response 1), intenders 
(responses 2-3), and actors (responses 4-6) based on the 3-stage HAPA (Schüz et al., 







2. Baseline characteristics  
Parents’ demographics (age, gender, marital status, level of education) and HIV-
related characteristics (route of infection, and time since diagnosis, antiretroviral therapy 
uptake, CD4 count, viral load) were collected at baseline. Children’s gender and age 
group (6-9 years, 10-12 years, and 13-16years) were also collected.  
Analysis 
The baseline (W1) and two follow-ups (W2 at 6-month and W3 at 12-month) data 
were used for this study. The analysis was conducted using Stata 13.0 (College Station, 
TX) and Mplus 7.4 (Muthen & Muthen). Somers' D was calculated to compare the 
distribution of HIV disclosure stage between the intervention and the control groups at 
W2 and W3.  
Intervention effect on HIV disclosure stage was examined using a first-order 
manifest Markov model by assuming that 1) the stage occupied at W3 depends only on 
the stage occupied at W2, not W1 (i.e., first-order); and 2) there was no measurement 
error in the stages (i.e., manifest). Details of the model can be found in Chapter 3, session 
3.7.3. Briefly, two regressions were conducted --- one for the stage membership at W2 
(U1) and one for the stage transition between W2 and W3 (U2). A multinomial logistic 
regression was conducted to model stage membership at W2. Conditional multinomial 
logistic regressions were conducted to model stage membership at W3 given a certain 
W2 stage membership.  
In terms of stage membership, no restriction was made on stage membership at 
W2. An absorbing stage of actors (e.g., no one could move out of this class) was defined 





Therefore, six possible transition patterns were modeled: static at pre-intention, forward 
transition from pre-intention to intention, forward transition from pre-intention to action, 
static at intention, backward transition from intention to pre-intention, and forward 
transition from intention to action.  
To test the equivalence of stage membership at W2 by intervention arms, the 
intervention arm was treated as a covariate. To test for the equality of transition matrix by 
intervention group, comparison of model fit was made between a model allowing 
different group-specific transition patterns (Model 1) and a model with a constraint on 
equal transition matrix across intervention arms (Model 2). Model fit was compared 
using log-likelihood ratio G2 difference tests (L. M. Collins, Fidler, Wugalter, & Long, 
1993). The Akaike Information Criteria (AIC) and the Bayesian Information Criteria 
(BIC) were also used. The entropy of models was also considered.  
In order to produce a broader picture of intervention effect on transition 
probabilities, unsuccessful and successful stage transitions were further defined. For pre-
intenders, forward transition to either the intention or the action stage was defined as 
“successful”, whereas no change was defined as “unsuccessful”. For intenders, a 
backward transition to the pre-intenders was defined as “unsuccessful”, whereas no 
change or forward transition to the action stage was defined as “successful”. Different 
categorization of the “no change” group was based on the fact that HIV disclosure 
preparation and planning can take much longer than 6 months. A study conducted among 
HIV-positive parents found that most “take years to prepare for disclosure, proceeding 
when they judge themselves ready to impart the news and their children receptive to 





Further, the baseline covariates influencing stage membership at W2 were 
included. These covariates were selected a priori (European Medicines Agency, 2015). 
As suggested by Streiner, “the ideal covariates are those that are related to intrinsic 
properties of the participants, such as age or sex, or are measured before the 
randomization” (Streiner, 2016). Moreover, according to the guideline on adjustment for 
baseline covariates in clinical trials, “the clinical and statistical relevance of a covariate 
should be assessed and justified from a source other than the current dataset” (Committee 
for Medicinal Products for Human Use, 2015). Therefore, Individual prognostic 
covariates were selected based on 1) previous observational studies conducted among 
PLHIV in Guangxi, China; 2) previous literature review regarding correlates of parental 
HIV disclosure (Adeoye-Agboola, Evans, Hewson, & Pappas, 2016; Hawk, 2007; 
Rochat, Stein, Cortina-Borja, Tanser, & Bland, 2017). Parent-level variables included 
parents’ age, gender, marital status, route of infection, and CD4 count. Child-level 
variables included gender and age group (6-9 years, 10-12 years, and 13-16years). 
Collinearity of individual-level covariates was checked using the variance inflation 
factors (VIF).   
The full information maximum likelihood (FIML) estimator was used to retain 
cases with missing data at either wave. It gives valid estimates when missing data are 
MCAR or missing at random (MAR) (Enders & Bandalos, 2001). Complete-case analysis 
was conducted for missing covariates. A sandwich estimator of standard errors was used 
to account for the clustered nature of data (patients were nested within clinics). Random 
start values were used to ensure that the models converge on global, rather than local 
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Figure 4.1 CONSORT flow diagram of 791 participants 
Results 
A CONSORT flow diagram was shown in Figure 4.1. Among all 791 who 
completed the baseline survey, participants who did not respond to the HIV disclosure 
question at both W2 and W3 were excluded from further data analysis. In total, 374 
participants from the intervention group and 377 participants from the control group were 












The distribution of baseline covariates by intervention group was shown in Table 
4.1. A total of 791 participants completed the baseline survey. The average age was 37.7 
years old, most participants were males (57.5%) and married (76.5%). Nearly half of the 
participants had only completed primary school education (46.5%). Around half of the 
participants were full-time employed (46.8%), and most had a monthly income of less 
than 1000 RMB (54.2%). More than a third (35.3%) were infected by their main 
partner/spouse, and nearly one fourth (23.9%) had a CD4 count greater than 500 
copies/ml. For children, around half were between 6 to 9 years old (47.7%), and most 
were boys (53.0%). No statistically significant differences were detected in the 
randomization check or the attrition analysis.  
Table 4.1 Baseline characteristics by intervention status 
 
Variables Intervention 
N = 403 
Control 
N = 388 
Total 
N = 791 
Parent level    
Socio-demographics 
Age 37.6±5.7 37.8±5.4 37.7±5.6 
Gender    
 Male 231(57.3) 224(57.7) 455(57.5) 
 Female 172(42.7) 164(42.3) 336(42.5) 
Marital status    
 Married 303(75.4) 301(77.6) 604(76.5) 
 Separated/divorced 41(10.2) 41(10.6) 82(10.4) 
 Widowed 58(14.4) 46(11.9) 104(13.2) 
Education completed    
 Primary school 169(43.0) 186(50.3) 355(46.5) 
 Middle school 195(49.6) 156(42.2) 351(46.0) 
 High school and higher 29(7.4) 28(7.6) 57(7.5) 
Employment    
 Unemployed 97(24.1) 58(15.2) 155(19.8) 
 Part-time 131(32.6) 131(34.3) 262(33.4) 
 Full-time 174(43.3) 193(50.5) 367(46.8) 
Income    






N = 403 
Control 
N = 388 
Total 
N = 791 
 1000-1999 125(31.0) 130(33.5) 255(32.2) 
 ≥2000 48(11.9) 59(15.2) 107(13.5) 
Clinical-related factors 
Route of infection    
 Spouse/main partner 144(35.7) 135(34.8) 279(35.3) 
 Commercial sex 121(30.0) 143(36.9) 264(33.4) 
 IDU 58(14.4) 49(12.6) 107(13.5) 
 Others 80(19.9) 61(15.7) 141(17.8) 
CD4 group    
  <200 77(19.5) 69(18.8) 146(19.1) 
 200-349 121(30.6) 117(31.8) 238(31.2) 
 350-500 99(25.1) 98(26.6) 197(25.8) 
 ≥500 98(24.8) 84(22.8) 182(23.9) 
Child-level    
Age group    
 6-9 199(49.3) 172(46.0) 371(47.7) 
 10-12 110(27.2) 86(23.0) 196(25.2) 
 13-18 95(23.5) 116(31.0) 211(27.1) 
Gender    
 Male 209(54.1) 185(51.8) 394(53.0) 
 Female 177(45.9) 172(48.2) 349(47.0) 
 
Descriptive analysis of HIV disclosure stage 
Distribution of HIV disclosure stage at W2 and W3 by intervention group was 
shown in Table 4.2. Somers’ D statistics suggested a statistically significant difference in 
HIV disclosure stage by intervention group at W3, but not W2.  













Intervention 173(46.8) 133(36.0) 64(17.3) 370(100.0) 0.019, p = 
0.628 Control 179(48.1) 134(36.0) 59(15.9) 372(100.0) 
W3 
Intervention 170(46.1) 127(34.4) 72(19.5) 369(100.0) 0.12, p = 






Intervention specific stage movement patterns 
Model fit statistics were shown in Table 4.3. A statistically significant difference 
in 𝐺2 was detected, suggesting that the unrestrained Model 1 was favored over the 
restrained Model 2 (p = 0.021). Therefore, unrestrained Model 1 was selected for further 
analysis. The chi-square test for MCAR showed no statistically significant effect (p = 
0.85), suggesting that the assumption of MCAR was met. The entropy was 0.95, 
suggesting a good model fit.  
Table 4.3 Model fit comparing the unrestrained Model 1 with the restrained Model 2 
 
 𝑮𝟐  H0 value 
ℓ 
No. of free 
parameters (p) 
Df = W – P - 
1 
AIC BIC 
Model 1 5290.58 -2645.29 13 4 5316.58 5376.66 
Model 2 5302.09 -2651.04 9 8 5320.09 5361.68 
Difference 11.51 4 p = 0.021 
 
The transition probabilities were shown in Figure 4.2. The probability of staying 
in a given stage is represented by a circle and the probability of transition is represented 
by either solid (for forward movement) or dashed (for backward movement) arrows. In 
the control group, among pre-intenders at W2, 78.3% stayed static at W3, 19.4% 
progressed to the intention stage, and only 2.3% progressed to the action stage. Among 
intenders at W2, 34.2% regressed to the pre-intention stage at W3, 57.7% stayed static, 
and 8.1% progressed to the action stage.  
In the intervention group, among pre-intenders at W2, 74.1% stayed static at W3, 
18.7% progressed to the intention stage, and only 7.3% progressed to the action stage. 
Among intenders at W2, 24.7% regressed to the pre-intention stage at W3, 58.8% stayed 





































Intervention effects on HIV disclosure stage membership at W2 and stage transition 
Intervention effects on stage membership were shown in Table 4.4. No 
statistically significant difference was detected for either pre-intenders (OR = 1.37, 95% 
CI 0.66, 2.84) or intenders (OR = 1.36, 95% CI 0.74, 2.48). Similar results were found 
after adjusting for baseline covariates, with the ORs being 1.45 (95% CI 0.66, 3.19) for 
pre-intenders and 1.53 (95% CI 0.79, 2.97) for intenders. 
Table 4.4 Intervention effect on W2 stage membership 
 
W2 stage membership Odds ratio 95% CI P-value 
Unadjusted model    
 Pre-intention 1.37 0.66, 2.84 0.483 





W2 stage membership Odds ratio 95% CI P-value 
 Intention 1.36 0.74, 2.48 0.401 
 Action (ref)    
Adjusted model    
 Pre-intention 1.45 0.66, 3.19 0.432 
 Intention 1.53 0.79, 2.97 0.289 
 Action (ref)    
 
Intervention effects on stage transition were shown in Table 4.5. Among pre-
intenders at W2, those in the intervention group were more likely to progress to the action 
stage rather than being static (OR = 3.43, 95% CI 1.17, 10.01). However, no statistically 
significant intervention effect was detected in promoting progression from pre-intention 
to intention (OR = 1.02, 95% CI 0.47, 2.20). Overall, no statistically significant 
intervention effect was detected in promoting a successful transition. Among intenders at 
W2, no statistically significant intervention effect was detected in preventing backward 
transition to pre-intention (OR = 0.71, 95% CI 0.35, 1.43), promoting forward transition 
to action (OR = 2.01, 95% CI 0.84, 4.79), or promoting overall successful transition (OR 
= 1.59, 95% CI 0.82, 3.09). Similar results were detected after adjusting for covariates.  
Table 4.5 Intervention effects on stage transition 
  
W2 stage W3 stage Successful 
transition  Pre-intention Intention Action 
Unadjusted model 
Pre-intention Ref 1.02(0.47, 2.20) 3.43(1.17, 10.01) 1.27(0.59, 
2.71) 
Intention 0.71(0.35, 1.43) Ref  2.01(0.84, 4.79) 1.59(0.82, 
3.09) 
Adjusted model 
Pre-intention Ref 1.07(0.49, 2.35) 6.66(1.72, 25.8) 1.42(0.65, 
3.13) 







This is one of the first efforts applying the HAPA in the evaluation of parental 
HIV disclosure interventions. Our results showed that the theory-based intervention 
yielded different effects when targeting PLHIV at different initial stages of HIV 
disclosure. Specifically, pre-intenders responded most to the intervention with higher 
odds of transition into action rather than staying at the pre-intention stage. However, for 
intenders, no statistically significant intervention effect was detected.  
Interestingly, our results showed that stage sequential change does not necessarily 
occur in a linear fashion as a small number of patients were found to skip stages out of 
the sequential order. Specifically, such pre-intenders skipped the intention stage and went 
directly to the action stage within the 6 months. One possible explanation, as mentioned 
earlier, was the measurement error which has the highest impact on the smallest response 
category (i.e., the pre-intenders) (Bassi, Hagenaars, Croon, & Vermunt, 2000). Another 
explanation was that the time window of 6 months was too wide to capture their 
sequential change. However, as mentioned earlier, it may take years before the intention 
is transformed into action. Further studies comparing the transition structure models with 
and without constraints on forward transition from pre-intention to action may help better 
understand whether such abrupt transition is possible. Moreover, if patients did actually 
make an abrupt transition without detailed planning and preparation, more studies are 
needed to disentangle predictors of such stage skipping and its corresponding 
consequences.  
Mixed findings have been reported regarding the efficacy of previous parental 





found no statistically significant difference in the presence or absence of parental HIV 
disclosure across conditions over 24 months. However, a previous parental HIV 
disclosure intervention conducted among PLH in Shanghai, China was found to promote 
movement along the disclosure behavior continuum as soon as 4 weeks after intervention. 
Noticeably, the Shanghai intervention was conducted among patients with teenage or 
adult children. The parental HIV disclosure literature showed that disclosure rates were 
higher among parents with older children compared to younger school-aged children. 
Moreover, if we look at the changes in the mean score of the 7-point disclosure behavior 
continuum, the intervention promoted participants’ movement from 1 (i.e., giving general 
information about HIV) to 3 (i.e., disclosing having a specific disease but not HIV). 
Therefore, such movement may suggest more of an increase in parent-child 
communication rather than the disclosure process posited in this study.  
The lack of intervention effect on the intention to action transition may also be 
explained by the variation of children’s age in our study. As mentioned earlier, around 
half of children were between 6 to 9 years old (47.7%), 25.2% were between 9-12 years 
old, and 27.1% were between 13-16years old. Previous studies have found a lower 
disclosure rate among parents with younger children as they were considered as “too 
young to understand”. However, age-appropriate disclosure for young children may not 
cover stigmatized and sensitive questions such as the route of infection, which has been 
identified as a key barrier for parental HIV disclosure. However, we were unable to test 
the moderating effect of child age due to the limited sample size.  
Several limitations exist in this study which may influence the interpretation of 





However, theoretically impossible backward stage transition out of the action stage was 
observed in this study. To cope with such measurement error, more complicated latent 
Markov models estimating the item-response probabilities can be used. Second, child age 
has been identified as one of the most consistent and influential predictor of parental HIV 
disclosure (Qiao et al., 2013). As child age increases, the incidence of parental HIV 
disclosure increases significantly. However, we were unable to test the moderating effect 
of child age due to the limited sample size.  
Despite these limitations, this study has significant implications for future studies. 
First, the 3-stage HAPA model can be applied to the evaluation of HIV disclosure 
interventions yet more complicated models such as the mover-stayer latent transition 
analysis need to be explored. Second, when assessing the intervention effects on stage 
transition, consideration of both specific transition probabilities and overall forward or 
backward transition patterns enables a more comprehensive interpretation of intervention 
effects. Third, the stage-specific intervention effects detected in this study indicate the 
need for stage-specific interventions which may be more effective in promoting stage 
transitions. To develop such tailored interventions, a better understanding of different 
predictors for each specific stage transition is warranted. Therefore, further mediation 
analysis exploring the mediating effects of such predictors on HIV disclosure stage 
transitions may help us elucidate the mechanism causing HIV disclosure stage transitions.  
 







4.2 PSYCHOSOCIAL FACTORS PREDICTING TRANSITIONS IN HIV DISCLOSURE 
STAGES --- EVALUATION OF A THEORY-BASED PARENTAL HIV DISCLOSURE 






















Several key psychosocial factors such as outcome expectancy and self-efficacy 
have been identified to influence HIV disclosure. However, when operationalized as a 
process with 3 stages according to the Health Action Process Approach (HAPA), the 
potential stage-specific roles of psychosocial factors on HIV disclosure stage transition 
have not been well studied.  
Using secondary data from a theory-based parental HIV disclosure intervention 
conducted among parents living with HIV in China, 2012, intervention effects on 
psychosocial factors such a parental HIV disclosure knowledge, disclosure outcome 
expectancy measured by perceived costs and rewards, disclosure action self-efficacy, and 
disclosure action planning were evaluated. Moreover, the predictive effects of such 
factors on HIV disclosure stage transition was examined.  
Guided by the stage model of the Health Action Process Approach (HAPA), three 
critical disclosure stages were defined: 1) the pre-intention stage, in which people have 
not yet decided to disclose; 2) the intention stage, in which people have decided to 
disclose but have not yet started action; 3) the action stage, in which individuals make 
actual disclosure event.  A latent change score (LCS) method was used to assess the 
intervention effect on disclosure-related psychosocial factors including knowledge, 
outcome expectancy (perceived costs and rewards), self-efficacy, and planning. 
Predictive effects of these psychosocial factors on disclosure stage transitions were 
examined by treating these factors as covariates in a Markov chain model estimating HIV 





At the first follow-up, statistically significant intervention effect was detected for 
disclosure knowledge (β=0.137, 95% CI 0.037-0.237, p=0.007), action self-efficacy (β = 
0.277, 95% CI 0.120, 0.434, p=0.001), and action planning (β = 0.344, 95% CI 0.168, 
0.519, p<0.001) but not for disclosure outcome expectancy. Stage-specific predictive 
effects of action self-efficacy and action planning on HIV disclosure stage transitions 
were detected. Specifically, the progression from pre-intention to intention was promoted 
by action self-efficacy and action planning, and regression from intention to pre-intention 
was prevented by action planning.  
The identification of stage-specific psychosocial predictors of stage transition 
allows matching future interventions to psychologically defined HIV disclosure stages. 
Introduction 
As reported on the 5th National Conference on HIV/AIDS in China, there were 
820,756 reported PLHIV in China by the end of June 2018, among which 80.4% were 
receiving ART (China Center for Disease Control and Prevention, 2018). The 2019 
UNAIDS special analysis reported that 83% of PLH who know their status have received 
the treatment, and 94% have suppressed viral loads (Joint United Nations Programme on 
HIV/AIDS, 2019). With prolonged lives thanks to ART, PLH face ongoing challenges 
regarding telling their HIV-positive status to children (i.e., parental HIV disclosure).  
According to the Disclosure Decision-Making Model (DDMM), parents assess 
the rewards and costs for HIV disclosure (i.e., outcome expectancy) and a decision to 
disclosure is made only when the rewards outweigh the costs (Chaudoir & Fisher, 2010). 
Also, parents evaluate their ability to disclosure (i.e., disclosure self-efficacy) in the 
decision-making process. The likelihood of disclosure increases as the rewards and self-





Such a linear relationship between psychosocial predictors and the likelihood of 
target behavior corresponds to the continuum model of behavior change (Lippke & 
Ziegelmann, 2008). In contrast, stage models of behavior change posit that people pass 
through qualitatively distinct, ordered phases during the process of behavior change 
(Weinstein et al., 1998). Therefore, the HIV disclosure process, according to the Health 
Action Process Approach (HAPA), can be measured with three critical stages: 1) the pre-
intention stage, in which people have not yet decided to disclose; 2) the intention stage, in 
which people have decided to disclose but have not yet started action; 3) the action stage, 
in which individuals make actual disclosure action (Schwarzer, Lippke, & Luszczynska, 
2011).  
Moreover, such stages are characterized by similarities within stages and 
psychological differences between stages (Schüz et al., 2008). Theoretically, pre-
intenders will show lower perceived rewards and self-efficacy but higher perceived costs 
than intenders. Intenders will show lower self-efficacy than actors, but no differences in 
perceived costs or rewards are expected. Therefore, for pre-intenders, higher levels of 
perceived rewards and self-efficacy, as well as lower levels of perceived costs, would 
promote stage progression. For intenders, higher levels of self-efficacy would promote 
stage progression, while lower levels of costs and higher levels of rewards would prevent 
stage regression.  
As emphasized by HAPA, as people pass different stages to make behavior 
change, self-efficacy should be differentiated by the stages of change (i.e., intention-
formation, behavior initiation, and behavior maintenance) (Schwarzer et al., 2003). In the 





with high action self-efficacy “imagine success, anticipate potential outcomes of diverse 
strategies, and are more likely to initiate a new behavior”. On the contrary, people with 
low action self-efficacy “imagine failure, harbor self-doubts, and tend to procrastinate” 
(Schwarzer, 2011).   
Noticeably, the HAPA posits that planning precedes the initiation of behavior 
change action. By planning, people first imagine a suitable future situation (“when” and 
“where”) for behavior change. A specific behavioral action (“how”) is expected to be 
effective for the intention to be translated into action in that situation. Among intenders, 
those who form action plans may be more likely to translate their intentions into action. 
Specifically, for HIV disclosure, patients create disclosure plans by setting disclosure 
goals, deciding where, when, and how to disclose, as well as seeking disclosure support 
(HIV/AIDS Resources & Comunity Health, 2016).  
Although previous studies have included psychosocial factors in program 
evaluation of parental HIV disclosure interventions, as no stage model was used to 
operationalize HIV disclosure, their roles in disclosure stage transition have not been well 
studied. The purposes of the present study are 1) to assess intervention effects on 
psychosocial factors, and 2) to assess the predictive effects of psychosocial factors on 
parental HIV disclosure stage transition.  The main hypotheses of the study are outlined 
in Table 4.6. Briefly, knowledge, outcome expectancy (costs and rewards), and action 
self-efficacy were hypothesized to influence 1) the progression from pre-intention; and 2) 
the regression from intention. Action planning was hypothesized to influence the 






Table 4.6 Hypothesis of stage-specific psychosocial predictors 
 
Stage Transition  Predictors Non-significant factors 
Pre-intention Progression Knowledge (+) Action planning 
  Perceived costs (-)  
  Perceived rewards (+)  
  Action self-efficacy (+)  
    
Intention Progression Action planning (+) Knowledge 
   Perceived costs 
   Perceived rewards 
   Action self-efficacy  
 Regression Knowledge (-) Action planning 
  Perceived costs (+)  
  Perceived rewards (-)  
  Action self-efficacy (-)  
(+) indicates high levels of the predictor and (-) indicates low levels of the predictor 
 
Methods 
Study setting and study sample 
This intervention was conducted in Guangxi, a southwest region ranked 3rd in 
terms of HIV prevalence in China. The top two cities (urban centers) and the top eight 
rural counties with the largest number of reported HIV/AIDS cases were selected as 
study sites. Within the 10 cities/counties, urban districts or rural with at least 200 
HIV/AIDS cases were identified, among which a total of 40 clinics were randomly 
selected. Within each clinic, 20 PLH who have not disclosed their HIV infection to their 
seronegative children aged between 6 to 15 years of age were randomly selected. Cluster 
randomization was used to assign each clinic into either the intervention or the control 
conditions. Baseline survey and 6-waves of follow-ups (every 6 months) were conducted. 





CDC in China and Wayne State University in the United States. All participants provided 
written informed consent. 
Description of intervention 
The intervention group received five 2-hour interactive training sessions with 
three specific components: child development, illness communication, and coping. 
Details of the components were summarized in Table 4.7. The control group received 
five 2-hour sessions of nutrition education curriculum. The nutrition curriculum was 
modeled after the “Simply Good Eating” curriculum (Sherman et al., 2012) and modified 
in accordance with current “Dietary Guidelines for Chinese Residents” (Ge et al., 2008).  
Table 4.7 Intervention components and corresponding sessions 
 
Intervention components Intervention sessions 
Understanding the stages of childhood 
cognitive development in the context of 
parental illness 
Session #1  
“Child’s readiness for disclosure” 
Improving the parents’ cognitive and 
behavioral skills related to parental HIV 
disclosure  
Session #2  
“Benefits and risks of disclosure” 
Session #3  
“How to tell and what to tell” 
Session #4  
“Disclosure is an ongoing  
Improving parental psychosocial well-
being in adapting to living with HIV/AIDS 
Session #5  
“Cope with my infection/illness”  
 
Intervention delivery and data collection 
Within each clinic, two trained facilitators delivered the materials through 
discussions, role-play, exercise, and/or games (for group sessions). The five two-hour 





weeks in the clinics where the parents are recruited. Two trained interviewers 
administered the baseline and all six-month follow-up surveys to the parents in a private 
room (e.g., doctor’s office). Participants completed the baseline survey before 
intervention and 6 waves of follow-ups were conducted every 6 months.  
Measures 
1. HIV disclosure stage 
One question was asked at both follow-ups to capture individual’s level of HIV 
disclosure: 1 = “having not started disclosure in the past 6 months and no intention to 
start”, 2 = “having not started disclosure in the past 6 months but is intending to start”, 3 
= “having not started disclosure in the past 6 months but already made a plan”, 4 =  
“started disclosing but not mentioning HIV”, 5 = “started disclosing with the word HIV”, 
and 6 = “started disclosing with the word HIV and how I got infected”.   
Based on the stage model of HAPA, the original 6 categories were collapsed into 
pre-intenders (response 1), intenders (responses 2-3), and actors (responses 4-6). These 
three stages of HIV disclosure were used in further analysis.  
2. Psychosocial factors 
Disclosure outcome expectancy was measured by the perceived costs and rewards 
of parental HIV disclosure. Disclosure costs were measured with 4 questions (e.g., “do 
you agree that disclosing to children will impact their academic performance?”), and 
disclosure rewards were measured with 5 questions (e.g. “do you agree that children will 
provide more support after knowing your status?”). Responses ranged from 1 = 





As the perceived costs and rewards depend on patients’ understanding of parental 
HIV disclosure, participants were also assessed on their knowledge regarding parental 
HIV disclosure using an author derived scale with 5 questions (e.g. “do you agree that 
parental HIV disclosure should take children’s developmental stage into consideration”). 
Responses ranged from 1 = “completely disagree” to 4 = “completely agree”.  
Action self-efficacy regarding parental HIV disclosure was measured with an 
author derived scale with 9 questions. Sample questions are “how confident are you that 
you can make a parental HIV disclosure plan?” and “how confident are you that you can 
talk with children about basic HIV/AIDS knowledge?”. Responses ranged from 1 = 
“completely unconfident” to 5 = “completely confident”.  
Action planning regarding parental HIV disclosure was measured with an author 
derived scale with 9 questions. Three general questions regarding when, who, and how to 
disclose and 6 specific questions (e.g., “how to explain what HIV is”, “how to deal with 
children’s reaction”) were asked. Responses were 1 = “will never consider”, 2 = “have 
not considered yet”, 3 = “considering”, and 4 = “already planned”.  
3. Baseline characteristics  
Parent-level variables include parents’ demographics (age, gender, marital status, 
level of education) and HIV-related variables (route of infection, and time since 
diagnosis, antiretroviral therapy uptake, CD4 count, viral load). Child-level variables 
include gender and age group (6-9 years, 10-12 years, and 13-16years).  
Analysis 
Only baseline (Wave 1 or W1), 6-month follow-up (Wave 2 or W2), and 12-





conducted in Mplus 7.4 (Muthen & Muthen). A proportional latent change score (LCS) 
method was used to evaluate intervention effect on psychosocial factors. Simply, the 
predicted changes are proportional to the state (or status) of the prior true score. 
Intervention assignment was treated as a predictor of latent change scores. In the 
measurement model, the latent construct of interest was measured using the observed 
items for each psychosocial variable. We assumed measurement invariance and 
correlated residual errors over time. Details of the model were depicted in Figure 4.3.  
In order to use information from cases with only baseline or only follow-up valid 
values in estimating the model parameters, the Full Information Maximum Likelihood 
(FIML) method was used. Robust (sandwich) variance estimator was used to account for 
clinic-level correlation, and potential baseline confounders were included.  
To assess whether psychosocial factors at W2 can predict stage transitions 
between W2 and W3, we first modeled the stage transition matrix. Details of the model 
specification can be found in manuscript 4.1. As backward transition from the action 
stage is not theoretically possible, six stage-specific transition patterns were modeled 
(Figure 4.4): static at pre-intention (A1), forward transition from pre-intention to 
intention (A2), forward transition from pre-intention to action (A3), static at pre-intention 
(B1), backward transition from intention to pre-intention (B2), and forward transition 







































Observed variable Latent variable Constant (e.g., mean, 
intercept) 
Directed relationship (e.g., factor 
loadings, regressions) 
 






































Second, the predictive effect of the proposed psychosocial factor at W2 on HIV 
disclosure stage transition was tested by including the estimated value at W2 based on the 
LCS model as a covariate for stage-specific transition probabilities. Intervention 
assignment was also included as a covariate for stage-specific transition probabilities. 
Parents’ age and gender, as well as the child’s age group and gender, were included as 
covariates influencing stage membership at W2 and W3. Details of the conditional 
multinomial logistic regression can be found in Table 4.8.  
Table 4.8 Predictive effect of psychosocial factors on stage transition 
 
 U2 











3 0 0 0 
Note: The b parameters are slopes for the multinomial regression of U2 on U1. The g 
parameters are slopes for the intervention. The h parameters are slopes for the estimated 
value of psychosocial factors at W2 based on the LCS model.  
 
 






Baseline characteristics by intervention group were shown in Table 4.9. Among 
all 791 participants who completed the baseline survey, the average age was 37.7 years 
old. Most were males (57.5%) and married (76.5%). Around half of participants had only 
completed primary school education (46.5%) and full-time employed (46.8%). More than 
half had a monthly income of less than 1000 RMB (54.2%). More than a third were 
infected by their main partner/spouse (35.3%), and less than one fourth had a CD4 count 
greater than 500 copies/ml 23.9%). Around half of the children were between 6 to 9 years 
old (47.7%), and most were boys (53.0%).  
Table 4.9 Baseline characteristics by intervention status 
 
Variables Intervention 
N = 403 
Control 
N = 388 
Total 
N = 791 
Parent level    
Socio-demographics 
Age 37.6±5.7 37.8±5.4 37.7±5.6 
Gender    
 Male 231(57.3) 224(57.7) 455(57.5) 
 Female 172(42.7) 164(42.3) 336(42.5) 
Marital status    
 Married 303(75.4) 301(77.6) 604(76.5) 
 Separated/divorced 41(10.2) 41(10.6) 82(10.4) 
 Widowed 58(14.4) 46(11.9) 104(13.2) 
Education 
completed 
   
 Primary school 169(43.0) 186(50.3) 355(46.5) 
 Middle school 195(49.6) 156(42.2) 351(46.0) 
 High school and 
higher 
29(7.4) 28(7.6) 57(7.5) 
Employment    
 Unemployed 97(24.1) 58(15.2) 155(19.8) 
 Part-time 131(32.6) 131(34.3) 262(33.4) 
 Full-time 174(43.3) 193(50.5) 367(46.8) 
Income    






N = 403 
Control 
N = 388 
Total 
N = 791 
 1000-1999 125(31.0) 130(33.5) 255(32.2) 
 ≥2000 48(11.9) 59(15.2) 107(13.5) 
Clinical-related    
Route of infection    
 Spouse/main 
partner 
144(35.7) 135(34.8) 279(35.3) 
 Commercial sex 121(30.0) 143(36.9) 264(33.4) 
 IDU 58(14.4) 49(12.6) 107(13.5) 
 Others 80(19.9) 61(15.7) 141(17.8) 
CD4 group    
  <200 77(19.5) 69(18.8) 146(19.1) 
 200-349 121(30.6) 117(31.8) 238(31.2) 
 350-500 99(25.1) 98(26.6) 197(25.8) 
 ≥500 98(24.8) 84(22.8) 182(23.9) 
Child-level    
Age group    
 6-9 199(49.3) 172(46.0) 371(47.7) 
 10-12 110(27.2) 86(23.0) 196(25.2) 
 13-18 95(23.5) 116(31.0) 211(27.1) 
Gender    
 Male 209(54.1) 185(51.8) 394(53.0) 
 Female 177(45.9) 172(48.2) 349(47.0) 
 
Intervention effects on psychosocial factors 
High internal consistency was observed for all five scales at both baseline and two 
follow-ups (Cronbach’s alpha 0.80 to 0.97). For parental HIV disclosure knowledge, 
statistically significant intervention effect was detected for change between W2 and 
baseline (β = 0.137, 95% CI 0.037, 0.237, p = 0.007), while no change was detected 
between W2 and W3 (β = -0.002, 95% CI -0.119, 0.115, p = 0.555). Regarding outcome 
expectancy, no statistically significant intervention effect was detected either for 
disclosure rewards or costs. Statistically significant intervention effect was detected for 
parental HIV disclosure self-efficacy between baseline and W2 (β = 0.277, 95% CI 














Figure 4.5 HIV disclosure stage transition matrix 
= 0.560). The intervention improved disclosure action planning both from baseline and 
W2 (β = 0.344, 95% CI 0.168, 0.519, p<0.001) and between W2 and W3 (β = 0.140, 95% 
CI 0.003, 0.277, p=0.045). Detailed results were shown in Table 4.10.  
Table 4.10 Intervention effects on psychosocial factors 
 
 Coefficients (95 % CI) P value 
W1 to W2   
Knowledge 0.137(0.037, 0.237) 0.007 
Rewards -0.006(-0.07, 0.058) 0.847 
Costs 0.078(-0.028, 0.184) 0.147 
Action self-efficacy 0.277(0.120, 0.434) 0.001 
Action planning 0.344(0.168, 0.519) <0.001 
W2 to W3   
Knowledge -0.002(-0.119, 0.115) 0.976 
Rewards -0.043(-0.126, 0.041) 0.316 
Costs 0.030(-0.071, 0.132) 0.558 
Action self-efficacy 0.057(-0.135, 0.249) 0.560 
Action planning 0.140(0.003, 0.277) 0.045 
 
HIV disclosure stage transition matrix 
The crude HIV disclosure stage transition matrix was shown in Figure 4.5. For 
pre-intenders at W2, 76.0% stayed static between W2 to W3, 19.3% progressed to 
intention, and 4.6% progressed to action. For intenders at W2, 57.8% stayed static 











Predictive effect of psychosocial factors on stage transition 
Predictive effects of psychosocial factors at W2 on stage transition between W2 
and W3 were shown in Table 4.8. The coefficients represent the effects of each 
psychosocial factor on the log odds ratio of each specific transition pattern compared to 
being static at W2 stage. Knowledge, perceived rewards, and perceived costs of parental 
HIV disclosure at W2 were not predictive of stage transitions between W2 and W3. 
Action self-efficacy increased the OR of progression from pre-intention to intention (OR 
= 2.00, 95% CI 1.16, 3.47) compared to being static at pre-intention. Action planning 
increased the OR of progression from pre-intention to intention (OR = 2.00, 95% CI 1.20, 
3.37) and decreased the OR of regression from intention to pre-intention (OR = 0.43, 
95% CI 0.18, 0.99). Details of stage-specific coefficients were summarized in Table 4.11.  
Table 4.11 Predictive effects of psychosocial factors at W2 on stage transition between 
W2 and W3 (odds ratio) 
 









Knowledge 2.05, p = 0.16 1.49, p = 0.52 0.48, p = 0.12 13.6, p = 0.23 
Rewards 1.51, p = 0.42 1.92, p = 0.33 0.58, p = 0.33 4.85, p = 0.40 
Costs 1.97, p = 0.23 0.54, p = 0.46 0.59, p = 0.33 72.2, p = 0.25 
Action self-
efficacy 
2.01, p = 0.013 1.99, p = 0.17 0.70, p = 0.20 0.38, p = 0.35 
Action planning 2.01, p = 0.008 2.44, p = 0.12 0.43, p = 0.047 2.12, p = 0.40 
 
Discussion 
Guided by the HAPA, this study tested the roles psychosocial factors play in the 
theory-based parental HIV disclosure intervention. At 6-month after the intervention, a 
statistically significant intervention effect was detected for disclosure knowledge, action 





specific predictive effects of action self-efficacy and action planning on HIV disclosure 
stage transitions were detected.   
Contrary to our hypothesis that the intervention will increase the rewards and 
decrease the costs of parental HIV disclosure, no intervention effect was detected. One 
major explanation is the measurement of outcome expectancy (Adams, Norman, Hovell, 
Sallis, & Patrick, 2009). First, the “right” items generated by researchers can make 
respondents aware of costs and rewards they may not have otherwise considered. Second, 
participants’ initial inaccurate understanding of parental HIV disclosure (e.g., a one-time 
“yes-no” event) may have already shifted to the more accurate “age-appropriate process” 
proposed by our intervention. Therefore, the corresponding costs and rewards may relate 
to different conceptualizations of HIV disclosure.  
Among the four previous parental HIV disclosure interventions, two evaluated 
intervention effects on psychosocial factors, especially disclosure self-efficacy (Conserve 
et al., 2017). Similar to our findings, Murphy et al., found a statistically significant 
improvement in disclosure self-efficacy 3 months after the intervention, which persisted 
to 9 months (Murphy et al., 2011). Simoni et al. detected a significant improvement in 
self-efficacy as soon as 4 weeks after the intervention, which persisted after 13 weeks 
(Murphy et al., 2011). In terms of the measurement, the Simoni study measured self-
efficacy with two items (how prepared/ready do you feel about making a decision on 
whether, when, and how to disclose your HIV status to your child?’; and ‘How 
prepared/ready do you feel about carrying out the decision you made on whether, when, 
and how to disclose your HIV status to your child?’). The Murphy study measured self-





0.90). Similar to the measure used in this study, participants’ confidence in deciding the 
child’s developmental readiness, making an age-appropriate plan, conduct disclosure, as 
well as deal with disclosure consequences (e.g., child’s emotional response, personal 
questions on HIV) were measured. These results suggest that parental HIV disclosure 
action self-efficacy can be improved within a relatively short time period.  
Stage-specific predictive effects of psychosocial factors were found. Specifically, 
motivational factors such as knowledge and outcome expectancy were not predictive of 
stage transitions. Studies guided by the transtheoretical model have revealed that the total 
pros scale reveals no significant differences between the Contemplation/Preparation 
(corresponds to the intention stage) and Action/Maintenance (corresponds to the action 
stage) stages (Kroll, Keller, Scholz, & Perren, 2011). More widely known as decisional 
balance, outcome expectancy is a multidimensional construct with more than two broad 
categories of pros and cons. The literature proposes four categories each for pros and 
cons (gains/losses for self or significant others, self-approval/disapproval or 
approval/disapproval from significant others) (Prochaska et al., 1994). Considering 
analyzing the potential receiver is a key component in HIV disclosure, further research is 
needed to distinguish the weighing of costs and rewards for parents themselves and the 
children. Moreover, the decisional balance literature suggests that in terms of behavior 
change, people not only weight the costs and rewards of the new behavior (i.e., HIV 
disclosure), but also the old behavior (i.e., non-disclosure) (S. E. Collins, Carey, & Otto, 
2009). Therefore, more complicated outcome expectancy measures are needed to capture 





Previous studies proposed self-efficacy as a universal facilitator of stage 
transitions as it predicts transitions between more than two stages (e.g., pre-intention to 
action) and in both directions (i.e., progression and regression) (Schüz et al., 2008; 
Schwarzer et al., 2007; Wiedemann et al., 2008). Our results suggest that the stage-
specific action self-efficacy was only predictive of pre-intention to intention progression, 
but not the progression from pre-intention to action. Moreover, action self-efficacy was 
not preventive of stage regression from intention. One possible explanation, as supported 
by a recent meta-analysis of studies applying the HAPA in health behavior contexts, was 
that action self-efficacy is influential in intention formation but not intention violation 
(Zhang, Zhang, Schwarzer, & Hagger, 2019). Also, as few people made the pre-intention 
to action transition, our ability to detect the predictive effects were limited by the small 
group size.  
HAPA posits the importance of action planning for the translation of behavioral 
intentions into behavior, not the formation of behavioral intentions. Our results indicate 
that action planning facilitated pre-intention to intention progression and prevented the 
intention to pre-intention regression. Therefore, participants in both the pre-intention and 
the intention stages would benefit from action planning. Previous research on other health 
behaviors showed that planning processes are important throughout all stages of change 
(Armitage, 2006; Schüz, Sniehotta, Wiedemann, & Seemann, 2006; F F Sniehotta, 
Araujo Soares, & Dombrowski, 2007). Another explanation is the difference between 
action planning and coping planning. According to HAPA, action planning emphasizes 
making when, where, and how plans while coping planning focuses on overcoming 





performance of intended behavior)” (Sniehotta, Schwarzer, Scholz, & Schüz, 2005). 
Given that parents face many barriers specifically in terms of the intention-to-action 
translation, more research on the role of coping planning in promoting intention to action 
transition is called for.  
Several limitations exist in this study which may influence the interpretation of 
our findings. First, we assumed no measurement error regarding HIV disclosure stage. 
However, theoretically impossible backward stage transition out of the action stage was 
observed in this study, suggesting potential misclassification bias. Second, due to the 
measurement issue mentioned earlier, the outcome expectancy measures might not be 
able to accurately capture participants’ perception of parental HIV disclosure as a 
process. Third, child age has been identified as one of the most consistent and influential 
predictor of parental HIV disclosure. However, we were unable to test whether stage-
specific predictors differ by child age due to relatively low stage transition probabilities.  
Despite these limitations, this study has significant implications for future studies. 
First, the breakdown in the conceptual theory of the program in terms of outcome 
expectancy indicates the need for further studies developing more accurate and complete 
measures that capture the construct multidimensionality. Second, considering 
psychosocial factors such as self-efficacy and planning predicted HIV disclosure stage 
transition, the inclusion of such factors as intervention components is warranted. The 
identification of such predictors also allows matching future interventions to 
psychologically defined HIV disclosure stages (i.e., stage-specific interventions). Third, 
as the traditional volitional psychosocial factors such as self-efficacy and planning were 





needed to examine psychosocial factors predicting intention to action progression. 
Fourth, further attention should be paid to participants who made pre-intention to action 
transition in terms of both study design (i.e., follow-up time interval) and data analysis 








DISCUSSION AND CONCLUSION 
5.1 SUMMARY OF THE DISSERTATION STUDY  
Using three waves (baseline, 6-month, 12-month) of secondary longitudinal data 
among 791 PLH participating an RCT of a theory-based parental HIV disclosure 
intervention, this dissertation study evaluated intervention effects on parental HIV 
disclosure process and disclosure-related psychosocial factors. Guided by the HAPA 
model, the dissertation study focused on three objectives as below:   
Study objective 1. This study adds to the literature of HIV disclosure by showing 
that HIV disclosure can be operationalized as a process with 3 different stages: pre-
intenders who don’t have disclosure intention, intenders who have disclosure intention 
but haven’t disclosed, and actors who have disclosed. Using a multi-group first-order 
Markov chain method, this study examined intervention effects on stage transition 
between months 6 and 12. Results indicated that this theory-based intervention yielded 
different effects for PLH at different initial stages of HIV disclosure. Specifically, pre-
intenders responded most to the intervention while no statistically significant intervention 
effect was detected for intenders.  
Study objective 2. Using a proportional Latent Chang Score (LCS) method, this 
study found a statistically significant intervention effect on disclosure knowledge, action 
self-efficacy, and action planning as soon as 6 months after the intervention. Moreover, 





months follow-ups. However, no intervention effect was detected on outcome expectancy 
measured by perceived costs and rewards of parental HIV disclosure.  
Study objective 3. Traditional motivational factors such as knowledge and 
outcome expectancy were not predictive of HIV stage transitions, while differential 
effects of traditional volitional factors such as self-efficacy and planning were found for 
pre-intenders and intenders. Action self-efficacy promoted pre-intention to intention 
progression but did not prevent intention to pre-intention regression. Action planning 
showed both a promoting effect on intention formation and a protective effect on 
intention regression. No factor hypothesized in this study was found to influence the 
intention to action transition.  
5.2 INTERPRETATION OF STUDY FINDINGS  
In terms of intervention effect on stage transition, our results suggested that the 
intervention promoted progression from pre-intention to action, but not from pre-
intention to intention. Intervention effect on such non-sequential stage transition can have 
three possible explanations. First, as mentioned earlier, was the measurement error which 
has the highest impact on the smallest response category (i.e., the pre-intenders) (Bassi et 
al., 2000). Second, the intervention may promote pre-intenders to skip the intention stage 
and go directly to the action stage within the 6 months (i.e., stage skipping). Third, the 
intervention may promote a quicker sequential transition from pre-intention to intention 
to action within 6 months. In terms of measurement error, more validation is needed to 
come up with an accurate HIV disclosure stage measure. In addition, further studies 
comparing the transition structure models with and without constraints on stage skipping 





considering the follow-up window of 6 months may be too wide to capture the quick 
transition, tighter follow-ups are needed to differentiate quick sequential transition from 
stage skipping.  
Regarding disclosure-related psychosocial factors, statistically significant 
intervention effects were detected as early as the first follow-up at month 6. Lack of 
intervention effect on outcome expectancy may be due to the measurement of such a 
construct. First, the “right” items generated by researchers can make respondents aware 
of costs and rewards they may not have otherwise considered. Second, outcome 
expectancy is a multidimensional construct. Besides the two broad dimensions of costs 
and rewards, whether such costs and rewards refer to oneself or significant others (in this 
case, the child) should be considered. Recently, an outcome expectancy scale for partner 
HIV disclosure identified five factors that were detected for both the costs and rewards 
(Cao, Mo, & Lau, 2019). Moreover, the weighing of costs and rewards not only depends 
on the targeted new behavior (i.e., disclosure) but also the old behavior (i.e., non-
disclosure). The dimensionality of HIV disclosure outcome expectancy needs to be 
examined and validated in further studies.  
5.3 LIMITATIONS  
Several limitations exist in this study which may influence the interpretation of 
our findings. First, the item measuring HIV disclosure stage has not been validated 
previously. Misclassification error may exist as theoretically impossible backward stage 
transition out of the action stage was observed among more than half of participants 
(64/119). Second, the literature suggests that outcome expectancy is a multidimensional 





significant others, self-approval/disapproval or approval/disapproval from significant 
others). Therefore, the two broad dimensions of costs and rewards may not fully capture 
the multidimensionality. Third, child age has been identified as one of the most consistent 
and influential predictor of parental HIV disclosure, both in terms of the likelihood of 
disclosure and the depth. Due to relatively low stage transition probabilities for certain 
patterns, we were not able to examine whether intervention effects, as well as stage-
specific predictors, differ by child age group. Finally, process evaluation was not 
conducted within this dissertation.  
5.4 IMPLICATIONS 
Despite these limitations, results from this dissertation study have significant 
implications for future research. First, the inclusion of intermediate outcome variables in 
the evaluation of HIV disclosure interventions which “aim more to diminish distress than 
achieve a specific behavioral outcome” is warranted (Simoni et al., 2015). The inclusion 
of such psychosocial factors not only enables us to capture the short-term intervention 
effects but also helps elucidate how such intermediate outcome variables relate to more 
distal outcomes (in this case, disclosure stage transition). as argued in HAPA, the 
influence of psychosocial factors is stage-specific. However, as the stage transition can be 
reversive (e.g., from pre-intention to intention, or from intention to pre-intention), 
whether the psychosocial factors can influence both directions is not clarified. For 
example, action self-efficacy is theoretically influential on intention formation, but 
whether it can both promote pre-intention to intention progression and prevent intention 
to pre-intention regression is not clear. Our results indicate that disclosure action self-





regression. This suggests action self-efficacy may be beneficial only for the pre-
intenders. Action planning, although theoretically influential only for intention 
translation, was found to promote disclosure intention formation as well as prevent the 
regression from intention to pre-intention. This suggests action planning can be beneficial 
both for the pre-intenders and intenders.  
Traditional stage-matched interventions guided by HAPA propose different 
intervention components based on participants’ stages. Pre-intenders are assumed to 
benefit more from motivational treatment focusing on risk communication, outcome 
expectancies, and action self-efficacy. Intenders are assumed to benefit more from 
volitional treatment focusing on coping self-efficacy, planning, and action control. 
Regarding parental HIV disclosure, our results suggest that the inclusion of action 
planning, a volitional treatment component usually addressed for intenders, may also 
benefit the pre-intenders. The inclusion of action self-efficacy, a motivational treatment 
component usually addressed for pre-intenders, may be needed only for the pre-intenders.  
5.5 FUTURE DIRECTIONS  
Future studies are needed for better measurement of HIV disclosure stage and 
disclosure-related psychosocial factors. Moreover, the theoretical transition patterns of 
HIV disclosure stage should be further examined. In addition, HIV disclosure stage is not 
the endpoint of intervention evaluation. The evaluation of parental HIV disclosure 
interventions may benefit from the consideration of the DPM embedded in the family 
setting.  
In terms of stage measurement, HIV disclosure was operationalized as a process 





for example, in the TTM, which assumes 5 stages, can be meaningful with regard to the 
differentiation of disclosure depth (e.g., partial vs. full) but have not been examined in 
this study. Moreover, within the 3-stage HAPA, researchers suggested that planning 
could be postulated as a moderator to further differentiate those who are at the intention 
stage (Sutton, 2008). It is possible that planning can be set as another stage separate from 
intention. Whether such finer-graded differentiations are meaningful for HIV disclosure 
stage should be examined in further studies.  
In terms of disclosure action self-efficacy, the social cognitive theory emphasizes 
that it should be tailored to a specific behavior under specific conditions (Bandura, 1997). 
Although we have considered specific tasks across the HIV disclosure process (e.g., 
deciding a child’s developmental readiness, making an age-appropriate plan, conduct 
disclosure, as well as deal with disclosure consequences), the “condition” component was 
not taken care of. As suggested by research regarding partner HIV disclosure, formative 
elicitation studies are needed to derive realistic situations regarding disclosure 
(Kalichman et al., 2001).  
The social cognitive theory argued that a true stage model is comprised of an 
ordered set of stages through which one must pass to reach the behavioral destination 
(Bandura, 1994). Therefore, the skipping of stages is not theoretically allowed. However, 
as one of the most widely used stage models, TTM assumes that stage transition can be 
cyclical. Studies have found that individuals are most likely to skip the preparation stage 
in TTM and try to move directly from contemplation into action (Britto et al., 2016; 
Rodkjaer, Sodemann, Ostergaard, & Lomborg, 2011). As the HAPA is conceptualized as 





skipping is possible in HAPA. Most studies guided by HAPA have collapsed the 
transition patterns into static, regression, and progression without differentiating the 
adjacent stage transition from stage skipping (Zhang et al., 2019). Short-period follow-
ups in longitudinal studies and qualitative studies may further help elucidate whether 
people move sequentially through the ordered stages within a short time or skip the 
intention stage.  
As argued in the DPM, besides the decision-making process, HIV disclosure 
process also includes the outcome process through which the disclosure event influences 
long-term individual (e.g., psychological and behavioral health), dyadic (e.g., intimacy 
and trust), and social contextual (e.g., stigma) outcomes. Therefore, the disclosure event 
should not be the endpoint of evaluation regarding parental HIV disclosure interventions. 
Further evaluation needs to be conducted regarding whether and how the HIV disclosure 
stage transition patterns influence both parents’ and children’s wellbeing, the dyadic 
parent-child relationship and family functioning, as well as HIV-related stigma.  
Finally, based on the family-based method, parental HIV disclosure happens in a 
family setting rather than at the interpersonal level (i.e., between the HIV-positive parent 
and the child) (Fisher & Weihs, 2000). Therefore, father-mother dyad also plays an 
important role in parental HIV disclosure. Firdawsi et al. (2014) posited a socio-
ecological model describing factors affecting parental HIV disclosure, where the 
presence of and the relationship with the partner, the HIV status of partner, as well as 
partner HIV disclosure, have been listed as key family-level components influencing 
parental HIV disclosure (Firdawsi, 2014). Moreover, although parental HIV disclosure 





HIV disclosure at the family level are needed to shed light on what individuals (e.g., 
healthcare providers, the positive parent, another caregiver, another family member) or 
teams (e.g., a parent-HCP team) can best convey parental HIV disclosure.  
5.6 CONCLUSION  
This dissertation study serves as a starting point of operationalizing HIV 
disclosure as a process of 3-stages using the HAPA. Consistent with the HAPA, stage-
specific intervention effects were detected. Action self-efficacy and action planning were 
detected as two key psychosocial factors influencing HIV disclosure stage transition. 
Further studies are needed to operationalize HIV disclosure stage under the guidance of 
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As parameters involving between-level variables are not allowed to vary across 
classes, the model treating c1 as a grouping variable cannot be used. Instead, intervention 
was treated as a between-level categorical latent variable and used as a grouping variable 
in data analysis. In the within part of the model, the random intercepts are shown in the 
picture as filled circles at the end of the arrows pointing to c1 and c2. They were referred 
to the cluster-level random effects as c1b and c2b (shown in the circles on the between 
level). The random intercepts have no variance within the classes of the between-level 
categorical latent variable “Intervention”. Individual-level factors were included as 










 Figure A.1 Multilevel Markov chain model 
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Results from the multilevel Markov Chain model were shown in Table A.1. 
Marginally significant intervention effects were detected for stage transition from pre-
intention to action compared to staying static at pre-intention.  
Table A.1 Intervention effects on stage transition (multilevel model) 
 
 
To model the intervention effect on psychosocial factors, a two-level latent 
change score model was conducted (Figure A.2). In the within part of the model, the 
filled circles at the end of the arrows from the within factors (M) to items. They represent 
random intercepts that are referred to as items 1-3 in circles in the between part of the 
model. In the between part of the model, the random intercepts are continuous latent 
variables that vary across clusters represented by factors bM1 – bM3. Latent change 
scores were also decomposed into within (LCS21 and LCS32) and between (bLCS21 and 
bLCS32) levels. In this model, the residual variances of the factor indicators in the 
between part of the model were fixed at zero. As the intervention was assigned to the 
clinics, it was treated as a between-level variable. Individual-level factors such as 
parents’ and children’s age and gender were included as within-level covariates 
influencing M1.  
W2 stage W3 stage Successful 
transition  Pre-intention Intention Action 
Unadjusted model 
Pre-intention Ref 0.98(0.39, 2.47) 3.34(0.95, 11.68) 1.23(0.50, 3.02) 
Intention 0.70(0.30, 1.63) Ref  2.01(0.71, 5.70) 1.60(0.72, 3.55) 
Adjusted model 
Pre-intention Ref 1.01(0.41, 2.53) 3.47(0.97, 12.38) 1.27(0.51, 3.13) 

































































Intervention effects on psychosocial factors based on the multilevel proportional 
LCS model were summarized in Table A.2. Noticeably, the multilevel model for action 
planning failed to converge. 
Table A.2 Intervention effects on psychosocial factors (multilevel model) 
 
 Coefficients (95 % CI) P value 
W1 to W2   
Knowledge 0.141(0.04, 0.242) 0.006 
Rewards -0.009(-0.077, 0.059) 0.787 
Costs 0.089(-0.027, 0.206) 0.134 
Action self-efficacy 1.199(0.792, 1.606) <0.001 
W2 to W3   
Knowledge 0.013(-0.097, 0.123) 0.816 
Rewards -0.04(-0.114, 0.034) 0.293 
Costs 0.053(-0.049, 0.155) 0.310 





TITLE:  MINPUT –Intervention effect on stage membership and stage transition 
 




NAMES ARE ID1 b c clinic status ageW1 A01W1 marital route cd4grp chdagegrp sex 
  ef1 ef2 ef3 r1 r2 r3 att1 att2 att3 difratio difeff difatt; 
    
 USEVARIABLES ARE ID1 b c clinic status  
  ageW1 female single divorce comsex blood other cd200 cd350 cd500 
  mid old girl ; 
  idvariable=ID1; 
  missing = all(-999); 
  CATEGORICAL ARE  b c; 
  classes are cb(3) cc(3) ; 
  cluster=clinic; 
 
define: 
female = 0; 
if (A01W1 eq 2) then female = 1; 
single = 0; 
if (marital eq 2) then single = 1; 
divorce = 0; 
if (marital eq 3) then divorce = 1; 
comsex=0; 
if (route eq 2) then comsex = 1; 
blood=0; 
if (route eq 3) then blood = 1; 
other=0; 
if (route eq 4) then other = 1; 
cd200 = 0; 
if (cd4grp eq 1) then cd200 = 1; 
cd350 = 0; 
if (cd4grp eq 2) then cd350 = 1; 
cd500=0; 




if (chdagegrp eq 2) then mid = 1; 
old=0; 
if (chdagegrp eq 3) then old = 1; 
girl = 0; 
if (sex eq 2) then girl = 1; 
CENTER ageW1 (GRANDMEAN); 
 
ANALYSIS: TYPE = mixture complex; 
 ALGORITHM=INTEGRATION; 
 INTEGRATION=MONTECARLO;  
STARTS = 400 40; 
PROCESSORS = 2; 
 
 model: 
 %overall%   
         [cc#1@-15 cc#2@-15]; 
         cc#1 on cb#1  (b11 ); 
         cc#1 on cb#2  (b12  ); 
         cc#2 on cb#1 (b21); 
         cc#2 on cb#2  (b22 ); 
         cb on status ageW1 female mid old girl single divorce comsex blood other 
         cd200 cd350 cd500; 
 
model cb: 
            %cb#1% 
            cc#1 on status (g11); 
            cc#2 on status (g21); 
      
            %cb#2%             
            cc#1 on status (g12); 
            cc#2 on status (g22); 
             
             %cb#3%             
            cc#1 on ; 
            cc#2 on ; 
 
 model cb: 
            %cb#1% 
            [b$1@15]; 
            [b$2@20]; 
            %cb#2% 
            [b$1@-15];  
            [b$2@15]; 
            %cb#3% 
            [b$1@-20]; 
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            [b$2@-15]; 
            
         model cc: 
            %cc#1% 
            [c$1@15]; 
            [c$2@20]; 
            %cc#2% 
            [c$1@-15];  
            [c$2@15]; 
            %cc#3% 
            [c$1@-20]; 
            [c$2@-15]; 
 
MODEL CONSTRAINT: 
new(log11_x0 log12_x0 log21_x0 log22_x0  
p11_x0 p12_x0 p13_x0 
p21_x0 p22_x0 p23_x0 
log11_x1 log12_x1 log21_x1 log22_x1  
p11_x1 p12_x1 p13_x1 
p21_x1 p22_x1 p23_x1 
lo_fwd_12 lo_fwd_13 lo_fwd_1 lo_bwd_21 lo_fwd_23 lo_noback_2 ); 
 
!coefficients in the control group 
log11_x0 = b11-15; 
log12_x0 = b21-15; 
log21_x0 = b12-15; 
log22_x0 = b22-15; 
p11_x0 = exp(log11_x0) / (exp(log11_x0) + exp(log12_x0) + 1); 
p12_x0 = exp(log12_x0) / (exp(log11_x0) + exp(log12_x0) + 1); 
p13_x0 = 1 / (exp(log11_x0) + exp(log12_x0) + 1); 
p21_x0 = exp(log21_x0) / (exp(log21_x0) + exp(log22_x0) + 1); 
p22_x0 = exp(log22_x0) / (exp(log21_x0) + exp(log22_x0) + 1); 
p23_x0 = 1 / (exp(log21_x0) + exp(log22_x0) + 1); 
 
!coefficients in the intervention group 
log11_x1 = b11 + g11-15; 
log12_x1 =  b21 + g21-15; 
log21_x1 = b12 + g12-15; 
log22_x1 =  b22 + g22-15; 
p11_x1 = exp(log11_x1) / (exp(log11_x1) + exp(log12_x1) + 1); 
p12_x1 = exp(log12_x1) / (exp(log11_x1) + exp(log12_x1) + 1); 
p13_x1 = 1 / (exp(log11_x1) + exp(log12_x1) + 1); 
p21_x1 = exp(log21_x1) / (exp(log21_x1) + exp(log22_x1) + 1); 
p22_x1 = exp(log22_x1) / (exp(log21_x1) + exp(log22_x1) + 1); 




!log odds ratio comparing two groups 
lo_fwd_12 = log((p12_x1 / p11_x1) / (p12_x0 / p11_x0)); 
lo_fwd_13 = log((p13_x1 / p11_x1) / (p13_x0 / p11_x0)); 
lo_fwd_1 = log(((1-p11_x1) / p11_x1) / ((1-p11_x0) / p11_x0)); 
lo_bwd_21 = log((p21_x1 / p22_x1) / (p21_x0 / p22_x0)); 
lo_fwd_23 = log((p23_x1 / p22_x1) / (p23_x0 / p22_x0)); 
lo_noback_2 = log(((p22_x1 + p23_x1) / p21_x1) / ((p22_x0 + p23_x0) / p21_x0)); 
 



















TITLE:  MINPUT –Intervention effect on psychosocial factors 
 
DATA:   File = C:\Users\wendi\Dropbox\Dissertation\Proposal\LCA-3stgitemsW3.csv; 
               
VARIABLE:  
 
NAMES ARE ID1 b c clinic status ageW1 A01W1 marital route cd4grp chdagegrp sex 
  ef1 ef2 ef3 r1 r2 r3 att1 att2 att3 difratio difeff difatt  
  Att_i1W1 Rew_i1W1 Rew_i2W1 Att_i2W1 Att_i3W1 Att_i4W1 Att_i5W1  
  Rew_i3W1 Rew_i4W1 Rew_i5W1 Cos_i1W1 Cos_i2W1 Cos_i3W1 Cos_i4W1  
  Eff_i1W1 Eff_i2W1 Eff_i3W1 Eff_i4W1 Eff_i5W1 Eff_i6W1 Eff_i7W1 Eff_i8W1 
Eff_i9W1 Att_i1W2 Rew_i1W2 Rew_i2W2 Att_i2W2 Att_i3W2 Att_i4W2 Att_i5W2  
  Rew_i3W2 Rew_i4W2 Rew_i5W2 Cos_i1W2 Cos_i2W2 Cos_i3W2 Cos_i4W2  
  Eff_i1W2 Eff_i2W2 Eff_i3W2 Eff_i4W2 Eff_i5W2 Eff_i6W2 Eff_i7W2 Eff_i8W2 
Eff_i9W2 Att_i1W3 Rew_i1W3Rew_i2W3 Att_i2W3 Att_i3W3 Att_i4W3 Att_i5W3  
  Rew_i3W3 Rew_i4W3 Rew_i5W3 Cos_i1W3 Cos_i2W3 Cos_i3W3 Cos_i4W3  
  Eff_i1W3 Eff_i2W3 Eff_i3W3 Eff_i4W3 Eff_i5W3 Eff_i6W3 Eff_i7W3 Eff_i8W3 
Eff_i9W3; 
 
USEVARIABLES ARE ID1 clinic status Att_- Att_i5W3 ageW1 female mid old girl; 
  idvariable=ID1; 
  missing = all(-999); 
  cluster=clinic; 
 
DEFINE: 
female = 0; 
if (A01W1 eq 2) then female = 1; 
mid=0; 
if (chdagegrp eq 2) then mid = 1; 
old=0; 
if (chdagegrp eq 3) then old = 1; 
girl = 0; 
if (sex eq 2) then girl = 1; 
 
CENTER ageW1 (GRANDMEAN); 
 
ANALYSIS: TYPE = complex; 
 ALGORITHM=INTEGRATION; 
 INTEGRATION=MONTECARLO (10);  
STARTS = 100 10; 
PROCESSORS = 3; 
 
MODEL: 
att1 by Att_i1W1@1; 
att1 by Att_i2W1 (1); 
att1 by Att_i3W1 (2); 
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att1 by Att_i4W1 (3); 
att1 by Att_i5W1 (4); 
 
att2 by Att_i1W2@1; 
att2 by Att_i2W2 (1); 
att2 by Att_i3W2 (2); 
att2 by Att_i4W2 (3); 
att2 by Att_i5W2 (4); 
 
att3 by Att_i1W3@1; 
att3 by Att_i2W3 (1); 
att3 by Att_i3W3 (2); 
att3 by Att_i4W3 (3); 
att3 by Att_i5W3 (4); 
 
Att_i1W1 with Att_i1W2 Att_i1W3 ; 
Att_i2W1 with Att_i2W2 Att_i2W3 ; 
Att_i3W1 with Att_i3W2 Att_i3W3; 
Att_i4W1 with Att_i4W2 Att_i4W3; 
Att_i5W1 with Att_i5W2 Att_i5W3; 
 
Att_i1W3 with Att_i1W2; 
Att_i2W3 with Att_i2W2; 
Att_i3W3 with Att_i3W2; 
Att_i4W3 with Att_i4W2; 


















att1 att2@0 att3@0; 





difatt1 by att2@1; 
difatt2 by att3@1; 
 
!Autoregression 
att2 ON att1@1; 
att3 on att2@1; 
 
!Proportional change  
difatt1 on att1(b); 
difatt2 on att2(b); 
 
difatt1 on status; 
difatt2 on status; 
att1 with status; 
 
OUTPUT: STDYX TECH1 SAMPSTAT SVALUES CINTERVAL;  
 
 
 
  
